





Designing and developing a novel, in vitro model 
to enable comparative assessment of 
regenerative endodontic scaffold materials 
 
Thesis submitted in accordance with the requirements of the University 
of Liverpool for the degree of Doctor of Dental Science in Endodontics by 
 
Nicholas Neil Longridge 





Regenerative Endodontic Procedures (REPs) are endodontic treatment strategies for 
managing teeth with immature root apices. Despite well reported clinical outcomes for these 
procedures, the role and influence of tissue scaffolds within this discipline requires greater 
investigation. Biological hydrogels are frequently used due to their high water content and 
analogous chemical composition to dental pulp. Variation in the chemical composition of 
hydrogels, along with tuneable mechanical characteristics and functionalisation can 
influence the phenotypic differentiation of local progenitor cells. Greater understanding of 
the interactions between progenitor cells and tissue scaffolds are required. 
Objectives 
Design and develop an in vitro model to enable comparative assessment of biological 
hydrogels for regenerative endodontic applications.  
Methodology 
Root canal analogues of varying diameters were designed using Materialise©3matic 
software and additively manufactured within a surrounding model - the ‘Culture Button 
Well’ (CBW) - by stereolithography using a Kulzer© caraprint4.0. Medical grade, type-1 
bovine collagen (6mg/ml) and gelatin from porcine skin (5% w/v) were used to produce 
three-dimensional cylindrical hydrogels within the CBW. Triple negative, human 
adenocarcinoma cells (MDA-MB-231) were fixed and seeded within the hydrogel cylinders 
and visualised within the CBW using a spinning disc confocal scanning laser microscope 
(Zeiss spinning disc axio-observer Z1). Invasion assays were attempted using L929 mouse 
fibroblasts and MDA-MB-231 cells that were seeded independently onto the upper 
compartment of the CBW, which contained 6mg/ml collagen hydrogels. Dulbecco’s 
modified eagles medium (DMEM) with 10% fetal calf serum and epidermal growth factor 
were used as chemoattractant within the lower compartment.  Chemically cross-linked 
gelatin cryogel discs were fabricated and L929 mouse fibroblasts were seeded onto the 
surface and cultured in DMEM for 7 days.  
Results 
Fixed and pre-seeded cells could be visualised within collagen hydrogels within the CBW 
without removal of the gels. Cells seeded onto the upper surface of collagen hydrogels 
demonstrated cell survival and growth at 3 days, but no invasion into the collagen hydrogels 
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was recorded. Cells seeded onto macroporous gelatin cryogels demonstrated cell migration 
into the gels at 7 days.  
Conclusions 
The CBW presents a novel, additively manufactured in vitro model to enable investigation 
of cell migration in 3D. The CBW can be produced quickly via multiple additive 
manufacturing techniques. The CBW can be modified to enable hydrogels with different 
dimensions and characteristics to be comparatively assessed. Macroporous gelatin cryogels 
demonstrated good cell migration into the scaffolds at 7 days and further investigation of the 
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1.1 Trauma and Dental Caries 
Trauma and dental caries are two common dental conditions that result in the loss of tooth 
substance. Frequently, these conditions require remedial restorative treatment to restore 
function, relieve symptoms and protect the underlying dental pulp. Whilst evidence exists to 
show a reduction in the prevalence of dental caries (Watt et al., 2013), the most recent UK 
Adult Dental Health Survey showed that 31% of dentate adults had evidence of coronal or 
root caries (White et al., 2011). Unfortunately, dental caries is a dynamic and often 
progressive process that can result in pulpal necrosis, leaving a non-vital, infected root canal 
space. Dental trauma is also prevalent within the population (Andreasen et al., 1995), 
especially in children (Forsberg and Tedestam, 1990, Krasner and Rankow, 1995). Whilst 
the stage of root development can influence the survival of the injured pulp (Ebeleseder et 
al., 1998), frequently dental trauma results in a significant, acute insult to the pulp that once 
again may lead to complete or partial pulpal necrosis (Andreasen, 2001). Loss of pulp 
vitality and vascularity can have significant consequences for patients, including pain, 
sepsis, tooth fracture and potentially tooth loss. Currently, pulpal necrosis is managed with 
conventional root canal treatment.  
1.2 Conventional Root Canal Treatment 
Root canal treatment (RCT), also known as endodontic treatment (ET), is still the treatment 
of choice for retaining non-vital teeth in which pulpal necrosis has occurred, with high 
success rates reported widely (de Chevigny et al., 2008, Farzaneh et al., 2004, Salehrabi and 
Rotstein, 2004, Ng et al., 2011). A systematic review and meta-analysis of over 300,000 
teeth showed the prevalence of RCT to be approximately ten percent, which was equivalent 
to two RCTs per patient (Pak et al., 2012). Of the remaining untreated teeth in this review 
(271,980), two percent displayed periapical radiolucency (PARL), which is consistent with 
pulpal necrosis. Alarmingly, up to 78% of RCTs were deemed technically inadequate, 
suggesting that non-surgical RCT and obturation pose a number of challenges when 
attempting to achieve an ‘adequate’ technical outcome. Another systematic review by 
Hamedy et al. highlighted that prevalence of non-surgical RCT and PARL increases with 
age, with 21% of subjects greater than 65 years of age having had RCT and a further 4% 
displaying PARL in the absence of RCT (Hamedy et al., 2016).  
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Gutta percha (GP) remains the gold standard root canal obturation material. However, 
despite all the proposed benefits of this inert material, bacteria regularly re-infect or re-
proliferate within the root canal system with root canal retreatment (Re-RCT) being 
required. Re-RCT is associated with lower success rates compared to primary RCT (Ng et 
al., 2011), due to the number of additional challenges and complexities arising from revising 
the initial RCT. The above research highlights that RCT is a significant issue for patients 
and health care providers worldwide, as well as being a disease that frequently goes 
untreated.  
1.3 Root Canal Treatment of Teeth with Immature Apices 
Obturation of affected teeth with immature apices is challenging to perform due to the large 
apical diameter and possible reverse taper (Trope, 2010). Traditionally, calcium hydroxide 
paste (Heithersay, 1975, Vernieks and Messer, 1978) has been used to produce a hard tissue 
apical barrier in a process referred to as ‘apexification’ (Rafter, 2005). The high pH of 
calcium hydroxide makes it antibacterial (El-Meligy and Avery, 2006). The caustic nature of 
calcium hydroxide produces a mild inflammatory reaction within the apical soft tissues that 
leads to formation of a mineralised barrier (Rafter, 2005), which then acts as the apical 
extent of the obturation. More recent methods involve the immediate placement of an apical 
barrier with a calcium silicate material such as Mineral Trioxide Aggregate (MTA) or 
Bioceramic putty (e.g. TotalFill Putty®) (Witherspoon and Ham, 2001). Whilst high success 
rates have been reported for both techniques (Mackie et al., 1988, Witherspoon et al., 2008), 
the immediate placement of an MTA barrier offers a number of benefits over calcium 
hydroxide, including; the reduced treatment time and number of appointments, but also the 
reported improved sealing ability of MTA (Nair et al., 2008). Ultimately, these techniques 
serve to eradicate infection and improve the prognosis of a compromised tooth, but they do 
not address the fact that immature teeth are more susceptible to fracture (Kerekes et al., 
1980). Furthermore, these techniques do not restore all of the benefits of the natural dental 
pulp and the pulp-dentine complex (PDC). A more contemporary, biological strategy for 
managing immature teeth, is to mechanically invoke bleeding into the root canal from the 
periapical tissues in a process referred to as ‘revascularisation’, ‘revitalisation’ or more 
collectively ‘Regenerative Endodontic Procedures’.  
1.4 Regenerative Endodontic Procedures and the gaps in the literature 
1.4.1 Status Quo and the Rise of Regenerative Endodontic Procedures 
Regenerative endodontic procedures (REPs) have emerged as an exciting and progressive 
discipline within the field of dentistry. Since the concept of revascularisation was introduced 
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in the 1960’s, a huge breadth of research has been directed towards the understanding of 
pulp biology, the reparative responses to pulp injury, and the potential benefits with its 
regeneration. Whilst true regeneration of the entire dental pulp has yet to be demonstrated 
histologically, clinical research continues to support REPs as a potential management 
strategy for the immature apex. Immature teeth have short roots, thin root canal walls and 
large apical foramina, which makes them more prone to fracture, more susceptible to 
mobility through periodontal disease and more difficult to manage with conventional 
endodontic treatment (Harlamb, 2016, Andreasen et al., 2002). The increases in root length 
and dentine thickness that have been reported with REPs could improve the prognosis for an 
immature tooth (Bose et al., 2009, Jeeruphan et al., 2012), which historically would have 
been subjected to prolonged calcium hydroxide intracanal medicaments in a process called 
apexification; from which, root fractures were a frequently reported sequelae (Andreasen et 
al., 2002). As discussed above, a more contemporary management strategy involves the 
immediate placement of an apical barrier with bioactive calcium silicate cements e.g. MTA. 
This progression from prolonged apexification with calcium hydroxide to immediate, root-
end barrier apexification with bioactive cements served to dramatically reduce the treatment 
time for young patients. Whilst the barrier method is associated with favourable clinical 
outcomes, it can be a difficult procedure to perform and achieve optimal technical outcomes 
due to large apical foramina, which can present with reverse taper anatomy. Furthermore, 
neither technique described above addresses the issues of short and thin root canal walls, 
which becomes increasingly relevant during the earliest stages of root development. Patients 
presenting at these early stages often display extremely short and thin root canal walls 
whereby extraction and prosthetic replacement may be the only viable management 
approach. For these reasons, researchers have continued to search for more biological 
treatment strategies aimed at increasing root length and wall thickness, whilst serving to 
manage any concomitant infection. Maintenance of pulp vascularity and innervation would 
also serve further protective functions through: the re-introduction of a positive pulpal 
pressure, which can reduce desiccation of root dentine and impede bacterial penetration; the 
presence of pulpal stromal cells and progenitor cells, that deposit tertiary dentine in response 
to insult; and the reintroduction of pulpal proprioception, a controversial phenomenon that 
may protect against the effects of excessive occlusal forces.  
1.4.2 Pulp regeneration in mature teeth 
A logical extrapolation of the successful clinical outcomes associated with immature apices, 
is to consider the potential for pulp regeneration in mature apices. Mature apices, being fully 
developed, do not require additional increases in root length and width to improve their long 
term prognosis. However, the presence of vital pulp tissue and the associated pulpal defence 
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mechanisms, would confer a number of potentially beneficial characteristics. As a future 
goal in pulp regeneration, the replacement of the conventional obturation material, GP, with 
a bioactive alternative serves as a major driving force in this rapidly advancing research 
field. The challenges associated with failed endodontic treatment and poorly obturated teeth 
suggest that biological alternatives are a desirable and realistic strategy for improving the 
oral health of patients and avoiding tooth loss. Furthermore, in broader terms, the tooth and 
the dental pulp serve as an extremely exciting model for tissue engineering, as the protective 
outer layers of enamel and dentine reduce the required mechanical characteristics of the 
biomaterial and as teeth are also removable, ethics considered, an ex vivo model with 
histological sampling may be feasible.  
Despite possible benefits of this strategy, there remains a great dearth of knowledge and 
research into the presence and role of progenitor cell niches at the apex of mature teeth. 
Stem cells of the apical papilla (SCAP) are frequently discussed in the literature as a viable 
stem cell source for cell homing strategies. However, it is not entirely clear what progenitor 
cells remain following apexogenesis and whether these niches are affected by pulpal 
necrosis, bacterial invasion and aging. Evidence has emerged to show different histological 
outcomes when REPs have been performed in partially vital teeth compared with non-vital 
cases (Shimizu et al., 2012, Shimizu et al., 2013). It is therefore clear that an in vitro model 
for pulp regeneration could provide a great amount of information regarding how stem cells 
interact with extracellular matrix (ECM) derivatives and their substitutes.   
1.4.3 Tooth Loss and Quality of Life 
It is well reported that tooth loss can have psychosocial consequences that have been shown 
to influence quality of life (Gerritsen et al., 2010). A reduction in chewing efficiency, speech 
changes and aesthetic concerns are some of the more common issues associated with tooth 
loss. Dental caries and traumatic dental injuries are common in children and young adults. 
Therefore, research into REPs stands to benefit a large cohort of patients for a long duration. 
Health economists have previously attempted to quantify the costs of different restorative 
strategies for teeth with pulpal necrosis and again tooth preservation through conventional 
endodontic treatment appears to have distinct cost benefits over extraction and prosthetic 
replacement. It stands to reason that regenerative treatments that could delay endodontic 
treatment and recover some inherent pulpal defence would represent good value for money 
for health services worldwide.  
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1.4.4 Gaps in the literature 
There remains a number of research areas within REPs that would benefit from an optimised 
and validated in vitro model. Firstly, and most fundamentally, cancer studies would suggest 
that there is a maximum distance away from a capillary that a mammalian cell can survive. 
This distance of 100-200µm has been attributed to the maximum diffusion distance of 
oxygen and is one of the contributing factors in the central necrosis of tumours. This 
distance is obviously insufficient for pulp regeneration. Beyond this distance, new vessels 
are required and the processes of angiogenesis and vasculogenesis are necessary (Carmeliet 
and Jain, 2000). A wealth of literature has discussed a wide range of pro-angiogenic cues as 
well as the complex interplay between cells, ECM and growth factors (Saberianpour et al., 
2018). Whilst this interplay has frequently been considered as a chemical relationship 
between cells and their growth factors, the mechanical characteristics of the ECM has also 
been shown to influence cell phenotype (Guilak et al., 2009, Wozniak and Keely, 2005) and 
in line with the great investment in tissue engineering strategies, understanding these 
interactions more thoroughly would serve to benefit pulp regeneration and the wider 
research community. 
An in vitro model for REPs would therefore enable greater research into: 
• Cell migration into tissue scaffolds including the speed of migration, cell-matrix 
interactions and cytokine expression.  
• Types of biomaterials including the influence of their mechanical properties and 
topography on cell behaviour.  
• Tissue scaffold porosity and porosimetry. 
• Effects of cytokines on the migratory behaviour of cells including growth factor 
gradients. 
• Comparative assessment of cell types and co-cultures on cell migration and 
angiogenesis.  





1.5 Aims and Objectives 
The primary aim of this project is to produce an in vitro model for studying cell migration 
and cell-ECM interactions in tissue scaffolds designed for regenerative endodontic 
procedures.  
This aim was subdivided into four primary objectives: 
1. Appraise the literature relating to tissue scaffolds in regenerative endodontic 
procedures, 
2. Design and additively manufacture a series of root canal analogues for in vitro use, 
3. Develop a range of biocompatible tissue scaffolds for use in the model, 
4. Validate the model design using the tissue scaffolds developed, 
Secondary objectives for this study included:  
1. Investigate the effect of different growth factor profiles on the speed and depth of 
cell migration.  
2. Investigate different tissue scaffold architecture e.g. porosity and pore size on speed 
and extent of cell migration. 
3. Investigate the effects of altering the mechanical properties of the tissue scaffolds on 
progenitor cell phenotype.  
4. Investigate the effects of scaffold functionalisation on cell migration.  
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2 Literature Review 
2.1 Dentine and the Pulp-Dentine Complex 
Dentine is an innervated, mineralised collagen network formed and supported by numerous 
pulpal cells, most notably odontoblast cells and their processes. Dentine is intricately linked 
with the underlying dental pulp and together they are commonly referred to as the Pulp-
Dentine Complex (PDC). Whilst these two tissues differ in composition, a synergistic 
relationship exists whereby dentine protects the pulp and the pulp supports dentine. Pashley 
discussed in detail the ‘Dynamics of the Pulp-Dentin Complex’ (Pashley, 1996). The organic 
component makes up 30% of dentine’s volume. It is predominantly type I collagen 
supported by a small percentage of non-collagenous proteins, proteoglycans and 
phosphoproteins, which induce and direct mineralisation.  
The pulpal microcirculation provides oxygen and nutrients to the cells of the PDC and it has 
been shown to confer protective benefits to the tooth. This includes a high hydrostatic tissue 
pressure which provides an outward flow of fluid from the dentinal tubules that adds 
resistance to the passage of pathogens and noxious substances from the external 
environment into the dental pulp (Nagaoka et al., 1995). This hydrostatic tissue pressure is 
only maintained by a functional PDC that is lost when the biological dental pulp is replaced 
with GP i.e. following conventional RCT. Furthermore, preservation of pulpal tissue has 
been shown to increase the damping ratio of premolar teeth when compared to non-vital and 
endodontically treated teeth (Ou et al., 2009). This provides greater dissipation of stress 
during function, which may provide additional resistance to fracture. Fundamentally, the 
PDC can enable regenerative and reparative processes to occur in response to insults such as 
caries and trauma, which are key protective events referred to as ‘tertiary 
dentinogenesis’(Sloan, 2015). This can include accelerated deposition of mineral by 
odontoblasts (reactionary dentine) and recruitment of local progenitor cells from pulpal 
niches (reparative dentine)(Goldberg et al., 2011, Smith et al., 1995). When pulpal necrosis 
occurs, these protective processes are lost and there is a greater risk of tooth loss, which is 
demonstrated by the improved success rates of pulpotomy (partial removal of inflamed pulp 
tissue) over pulpectomy (complete removal of all pulp tissue) (Taha and Abdelkhader, 2018, 
Ng et al., 2008). Despite the benefits of a functional PDC being widely acknowledged, the 
preservation of the natural pulp is frequently unachievable. For this reason, considerable 
research is being conducted into the production of biological substitutes for the pulp with 
subsequent regeneration of the PDC being the ultimate, desirable aim. These research topics 
and treatment strategies are collectively referred to as ‘Regenerative Endodontic Procedures’ 
(Diogenes et al., 2013) and can be considered to be a branch of tissue engineering.  
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2.2 Regenerative Endodontic Procedures 
2.2.1 History of REPs 
Regenerative Endodontic Procedures (REPs), sometimes referred to as revascularisation or 
revitalisation, are alternative treatment strategies to conventional RCT that aim to regenerate 
the dental pulp and PDC. They have been defined as ‘biologically based procedures 
designed to replace damaged structures, including dentin and root structures, as well as cells 
of the pulp-dentin complex’ (Murray et al., 2007). Research conducted over forty years ago 
identified that periapical stimulation of blood flow into previously devascularised root canal 
systems led to connective tissue ingrowth (Nygaard-Ostby and Hjortdal, 1971) and since this 
time countless studies have looked at the various procedural steps involved in regenerating 
the dental pulp (Albuquerque et al., 2014, Diogenes et al., 2013, Murray et al., 2007, Iwaya 
et al., 2001). REPs have been shown to support continued root development resulting in 
apical closure, increased root length and root thickness (Thibodeau et al., 2007, Wang et al., 
2010). Histologically, these tissues have been identified in both animal and human studies, 
as mineralised tissue closely resembling cementum and bone (Wang et al., 2010, Shimizu et 
al., 2013, Yamauchi et al., 2011a, Yamauchi et al., 2011b), with pulp-like tissue also 
identified (Shimizu et al., 2012, Albuquerque et al., 2014). The absence of apical infection 
and the presence of apical papilla or vital apical pulp tissue may be important prognostic 
factors in these cases (Shimizu et al., 2012, Shimizu et al., 2013).  
Incomplete root development remains a significant prognostic factor in trauma management 
with greater risk of pulpal necrosis in teeth with mature root apices (Andreasen and 
Pedersen, 1985). The diameter of the apical foramen is therefore considered to be an 
important prognostic factor for success of REPs, with research from the 1980s 
demonstrating that spontaneous revascularisation of avulsed incisors only occurred when the 
apical diameter exceeded 1mm (Kling et al., 1986). Immature apices were radiographically 
measured between 0.5mm and 5mm within this study.  
2.2.2 Requirements for REPs 
As with most tissue engineering research, REPs focus on a number of key issues briefly 
summarised below (Langer and Vacanti, 1993): 
1. Mesenchymal Stem Cells. 
2. Tissue Scaffolds. 
3. Growth factors e.g. Stromal Cell-Derived Factor-1 (SDF-1). 
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Furthermore, REPs have additional considerations due to the role of pathogens in the demise 
of the dental pulp in an enclosed microenvironment: 
4. Disinfection/Preparation of the Root Canal System. 
2.2.3 Cell homing vs cell transplantation 
As progenitor cells are required for tissue regeneration, the application or recruitment of 
these progenitor cells relies upon one of two strategies. The first strategy, cell homing, 
involves the recruitment of progenitor cells from local stem cell niches. Evidence-based 
clinical protocols recommended by both the American Association of Endodontists 
(Diogenes et al., 2013) and European Society of Endodontics (Galler et al., 2016) promote 
the use of the cell homing strategy. In comparison, cell transplantation techniques extract 
progenitor cells from alternative sources, such as extracted or stored deciduous teeth, and 
transplant the cells into the desired site or scaffold. Whilst multiple sources of progenitor 
cells in the oral tissues have been reported, the potential differentiation profile of each will 
vary. As such, the resultant tissue profiles that may be possible are likely to be directly 
linked to the progenitor cell source (Sharpe, 2016). As cell transplantation protocols require 
an additional source, they have been less widely researched when compared to cell homing 
strategies, which are already being utilised in current clinical procedures and are therefore 
less confined by ethical considerations. As such, there continues to be great interest in cell 
homing strategies, which rely upon appropriate chemical cues to orchestrate cell migration. 
Of particular interest is the release of dentine matrix components (DMCs) that are 
sequestered in dentine during tooth development or extracted and added to bioactive tissue 
scaffolds (Duncan et al., 2018).  
2.2.4 Disinfection of the root canal system 
The volume of literature detailing the effect of endodontic irrigants and medicaments upon 
pathogens, dentine and local progenitor cells has been increasing (Trevino et al., 2011, 
Galler et al., 2011, Ruparel et al., 2012, Essner et al., 2011, Althumairy et al., 2014, 
Chuensombat et al., 2013, Yassen et al., 2013). This area remains contentious due to the 
wide range of treatment protocols utilised in published case reports that have reported 
successful outcomes (Diogenes et al., 2013). However, it has been shown that the traditional 
use of double or triple antibiotic pastes (DAP/TAP) can significantly affect the cell viability 
of DPSCs and SCAP (Ruparel et al., 2012). Furthermore, use of TAP has been associated 
with tooth discolouration (Miller et al., 2012), difficult removal from the canal (Berkhoff et 
al., 2014) and potential development of antibiotic resistance. Interestingly, calcium 
hydroxide and metronidazole have displayed fairly positive results in a number of these 
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studies with regards to stem cell toxicity (Althumairy et al., 2014, Chuensombat et al., 2013, 
Ruparel et al., 2012). As a result, the European Society of Endodontology position statement 
on revitalisation procedures recommends the use of sodium hypochlorite irrigation (1-3%) 
and calcium hydroxide intracanal medicament (Galler et al., 2016). Further research into this 
area will consolidate the international opinion regarding disinfection protocol. The 
conventional approach in REPs classifies disinfection of the root canal system as stage one 
of a two-stage procedure. Stage two involves stimulation of bleeding into the root canal from 
the periapical tissues with or without the use of an appropriate tissue scaffold. As discussed 
earlier, the presence of bacteria within the apical tissues is likely to play an important role in 
the potential for regeneration (Shimizu et al., 2012, Shimizu et al., 2013) and as such the 
disinfection of teeth where pulpal necrosis has occurred is likely to remain a popular 
research topic.  
2.2.5 Growth factors/Morphogens 
The role of growth factors in the recruitment of cells to the site of injury can be 
demonstrated in the cellular processes associated with wound healing (Velnar et al., 2009). 
At present, the exact reparative or regenerative processes associated with cell homing in 
REPs are not fully understood. However, as with wound healing, it is well accepted that the 
co-ordinated release of growth factors by cells or ECM can influence the resultant cell 
recruitment and differentiation, which is vital if true pulpal regeneration is to be achieved. 
Growth factors are sequestered within dentine during tooth development (Duncan et al., 
2018). Under pathological circumstances, such as dental caries, demineralisation releases 
potent chemotactic agents, such as transforming growth factor beta (TGF-β), platelet derived 
growth factor (PDGF) and vascular endothelial growth factor (VEGF), that contribute to the 
reparative and reactionary processes of tertiary dentinogenesis (Galler et al., 2011, Smith et 
al., 1995). The use of ethylene-diamine-tetra-acetic acid (EDTA) as a dentine conditioner 
during REPs has been studied, with research showing development of dentine associated 
mineralised tissue (DAMT) (Yamauchi et al., 2011b). Interestingly, hair-like projections 
from the regenerated DAMT into the demineralised dentine were only evident when EDTA 
was utilised. Alongside the growth factors above, a wide array of additional cytokines and 
growth factors deemed ‘mobilisation’ factors have also been reported, due to their strong 
chemotactic effects including stromal-cell derived factor-1 (SDF-1) and granulocyte-colony 
stimulating factor (G-CSF)(Duncan et al., 2018), some of which have also been incorporated 
into tissue scaffolds in current pulp regeneration studies (Albuquerque et al., 2014). 
Studying the potential sources of these morphogens and the roles they play in cell homing 
remains an important topic for REPs. Furthermore, the ability to design tissue scaffolds that 
release cytokines upon degradation, or extract growth factors from dentine is an additional 
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facet to the complex interactions between the tissue engineering triad of stem cells, 
morphogens and tissue scaffolds.  
2.3 Adult Progenitor cells of the head and neck 
2.3.1 Stem/progenitor cell niches and markers 
Mesenchymal stem cells (MSCs) like all stem cells are capable of self-renewal and multi-
lineage differentiation. They are postnatal stem cells, which despite having less plasticity 
than embryonic stem cells, are less confined by legal and ethical issues (Murray et al., 2007). 
MSCs are multi-potent, neural crest derived cells, that can differentiate into the skeletal 
structures of the body including bone and connective tissue (Caplan, 1991). A number of 
sources have been identified including a large number in the tissues of the head and neck 
(Diogenes et al., 2013, Surendran and Sivamurthy, 2015, Liu et al., 2006, Huang et al., 2009, 
Sharpe, 2016): 
• Stem Cells of the Apical Papilla (SCAP). 
• Dental Pulp Stem Cells (DPSCs). 
• Periodontal Ligament Stem Cells (PDLSCs). 
• Stem Cells from Human Exfoliated Deciduous Teeth (SHEDs). 
• Dental Follicle Stem Cells (DFSCs). 
• Gingival Fibroblastic Stem Cells (GFSCs). 
• Dental Implant Stem Cells (DISCs). 
These cells are present in each individual and as such can be harvested to produce 
autologous stem cell populations that can be used for tissue engineering within the same 
individual with fewer legal, ethical and immunological contra-indications (Murray et al., 
2007). Due to the range of cells isolated from different sources, the document ‘minimal 
criteria for defining multi-potent mesenchymal stem cells’ was published in 2006 (Dominici 
et al., 2006). According to this criteria, MSCs should: 
• Adhere to plastic. 
• Express specific surface antigens – CD105, CD73, CD90.  
• Tri-lineage in vitro differentiation – Osteoblasts, Adipocytes, Chondroblasts.  
The method of isolation has also been identified as an important prognostic factor in 
regenerative potential (Nakayama et al., 2017) and a large amount remains unknown. 
Isolating specific MSCs populations can be challenging due to the range of cell markers that 
are common across stem cell populations. Kawashima discussed ‘candidate markers of 
DPSCs’ in great detail (Kawashima, 2012). In this paper, a range of common mesenchymal 
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cell markers were discussed, including STRO-1, CD29, CD73, CD105, CD146. Specific 
stem cell markers for haematopoietic progenitors are also highlighted including CD34 and 
CD117. Strategies for isolating DPSCs may include: the dental pulp explant method; 
antibody-conjugation with cell surface markers detailed above; isolation of dental pulp cells 
with the highest growth rate; and isolation of cells with the ability to remove fluorescent 
binding dye through membrane efflux pumps (Kawashima, 2012, Huang et al., 2006).  
2.3.2 Dental Pulp Stem Cells and Stem Cells of the Apical Papilla 
The specific source of adult progenitor cells has been the source of great interest in REPs. A 
wide range of MSCs have been identified in the tissues of the head and neck (Sharpe, 2016), 
many of which are outlined above. Of most significance to REPs are stem cells of the apical 
papilla (SCAP) and dental pulp stem cells (DPSCs), which can be recruited into the root 
canal by cell homing strategies. Whilst Bone-marrow mesenchymal stem cells (BMMSCs) 
and MSCs from the head and neck share similar immunophenotypes (Gronthos et al., 2000), 
the exact relationship between different populations of MSCs remains unclear. DPSCs and 
SCAP have shown high levels of dentinogenic/osteogenic differentiation as well as potential 
neuronal differentiation, but lower adipogenic differentiation (Gronthos et al., 2000). In 
contrast, BMMSCs have shown osteogenic and adipogenic differentiation (Gronthos et al., 
2000), but dentinogenic differentiation has not been identified (Huang et al., 2008). This 
supports the use of adult progenitor cells that reside most closely to the root canal, with 
DPSCs found within the central pulp of vital teeth shown to differentiate into both 
odontoblasts and also endothelial cells, making them ideal cells for pulp tissue regeneration 
(Cavalcanti et al., 2013). It is becoming apparent that different populations and side-
populations of stem cells show greater potential for REPs. Of particular note is the use of 
side-population DPSCs utilised by Nakashima and Iohara, which includes CD105+ and 
CD31-/CD146- stem cells (Nakashima and Iohara, 2014). Furthermore, the exact source of 
DPSCs following tooth injury remains an area of research, with both pericytes and glial cells 
reported as potential precursors of DPSCs and their post-differentiation cells, odontoblasts 
(Sharpe, 2016).  
2.4 Tissue Scaffolds 
2.4.1 Broad classification of tissue scaffolds 
Biomaterials have been defined by the European Society of Biomaterials as ‘a material 
intended to interface with biological systems to evaluate, treat, augment, or replace any 
tissue, organ or function of the body’ (O'Brien, 2011). With this in mind, tissue scaffolds are 
biomaterials used to replicate ECM of healthy tissues that have subsequently been damaged 
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by trauma or disease. Tissue scaffolds, sometimes referred to as cellular scaffolds, can be 
natural polymers (e.g. collagen), synthetic polymers (e.g. poly-lactic acid), ceramics (e.g. 
hydroxyapatite) or a composite of two or more materials (Ricapito et al., 2016, O'Brien, 
2011). These materials are required for cell attachment, migration and proliferation, but 
should also enable metabolite and nutrient exchange before biodegrading appropriately as 
cells produce natural ECM for support (Dhandayuthapani et al., 2011). For this reason, it is 
essential that tissue scaffolds are porous structures with well interconnected pores (Loh and 
Choong, 2013). In early animal models, non-porous scaffolds did not encourage 
osteogenesis (Kuboki et al., 1998) and implant studies have shown that porous scaffolds may 
provide mechanical benefits over solid surfaces due to interlocking with natural tissues 
(Story et al., 1998).  
2.4.2 Scaffold properties, production and functionalisation 
In their simplest form, a tissue scaffold can be visualised as a series of vacant pores within a 
polymeric structure analogous to a piece of sponge or honeycomb. Tissue scaffolds can be 
fabricated via a number of different strategies including conventional techniques such as 
porogen leaching, cryogelation, gas foaming and emulsion freezing (Bencherif et al., 2013). 
More recent advances in additive manufacturing and extrusion/inkjet technology has 
provided the foundations for computer aided manufacturing processes such as fused 
deposition modelling (FDM), stereolithography (SLA), selective laser sintering (SLS) and 
bioprinting (Woodfield et al., 2004, Duan et al., 2010, Derby, 2012, Vanderburgh et al., 
2017). Each fabrication technique will significantly influence the resultant architecture and 
mechanical structure of the tissue scaffolds including pore size, pore shape, pore volume and 
interconnectivity, which in turn may have significant effects upon cell behaviour and tissue 
development (Murphy and O'Brien, 2010, Hollister, 2005, Druecke et al., 2004), especially 
where vascularised tissues are required (Mehdizadeh et al., 2013, Novosel et al., 2011). 
Whilst greater porosity may allow for greater cell migration and nutrient exchange, these 
advantages come at the expense of reduced cell attachment and mechanical rigidity (Murphy 
and O'Brien, 2010, O'Brien et al., 2007). Therefore, a balance must be achieved between the 
need for cell space to migrate and ligands for cell attachment. This has driven the 
investigation into cell and tissue specific scaffold design, with optimisation of the scaffold 
required for each specific biological function (Karageorgiou and Kaplan, 2005, Mehdizadeh 
et al., 2013). Scaffolds that display pore sizes of less than 10 microns are considered 




Using conventional methods like porogen leaching, the pore size can be controlled through 
careful sieving of the porogen i.e. salt particles of specified diameter can be pre-measured 
and used (and removed). However, precise control over the pore size is difficult and a pore 
size range is normally achieved. By comparison, additive manufacturing strategies may 
precisely recreate exact pore shapes and sizes, but are restricted by the range of polymeric 
materials available and by the technology with regard to the smallest pore dimensions 
achievable (Derby, 2012). Interconnectivity, refers to the degree of communication between 
subsequent pores and is a fundamental design consideration for tissue engineering, where 
cell migration and nutrient exchange is pivotal (Murphy et al., 2010). With this concept in 
mind, cryogelation produces highly interconnected pores due to the contact of adjacent ice 
crystals during freezing. In contrast, gas foaming involves the addition of gas bubbles to the 
polymer, which has been associated with fewer interconnected pores, as the thin polymeric 
lining of each bubble can sometimes remain.  
Aside from the influence of various production methods on scaffold architecture, tissue 
scaffolds can also be pre-seeded with cells or functionalised with growth factors in an 
attempt to enhance the regenerative capacity of the scaffold. The quest for engineered 
vascularised tissues has seen a large amount of interest in the incorporation of pro-
angiogenic growth factors such as VEGF (Jain et al., 2005) and TGF-β1 (Piva et al., 2014, 
Lovett et al., 2009, Rouwkema et al., 2008). Functionalisation of scaffolds can also refer to 
the addition of enzymes or molecules that can increase the binding sites for cells or influence 
the physical behaviour of the scaffold to make them temperature or pH responsive. 
2.4.3 Extracellular matrix and its constituents 
ECM represents the non-cellular component of tissues. It is a dynamic structure which 
supports and modulates cellular activity and is constantly modified and recycled by a 
number of enzymatic and non-enzymatic processes (Frantz et al., 2010). Whilst collagens 
are the predominant fibrous proteins (Gordon and Hahn, 2010), the exact composition of 
ECM is tissue and site specific. Broadly speaking, ECM can be subdivided into interstitial 
matrix and basement membrane, the latter of which could be considered a specialised ECM 
structure that predominantly contains collagen type IV and laminin (LeBleu et al., 2007). In 
contrast, collagen type I is the most abundant interstitial protein. However, the exact 
composition of each component is varied. 
In the context of regenerative endodontic procedures, tissue scaffolds should closely 
resemble the ECM of the dental pulp, a vascular, loose connective tissue composed 
primarily of collagen (Type I and III) and ground substance (e.g. glycosaminoglycan) 
(Goldberg and Smith, 2004). Pulpal necrosis, which can occur in response to dental caries 
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and trauma, results in the demise of this vascular connective tissue and is the target tissue for 
regeneration in REPs. It is therefore prudent to investigate possible biomaterials for REPs 
that can closely resemble dental pulp in terms of topographical architecture, mechanical 
properties and bioactivity (Chan and Leong, 2008). These materials should be non-cytotoxic 
with low immunogenicity and should be appropriately biodegradable to allow replacement 
with endogenously synthesised ECM. It is therefore no surprise that many natural polymers 
such as collagen, hyaluronic acid, alginate and chitosan have been investigated (Chrepa et 
al., 2017). 
ECM composition has been shown to influence cell behaviour, but the full intricacies of cell-
ECM interactions are not fully understood and are currently an area being researched widely 
(Guilak et al., 2009). Whilst the presence of various chemical molecules within the ECM is 
likely to have a strong influence upon cell viability and activity, it is also now more widely 
recognised that the physical composition of the ECM itself will also modulate the 
attachment and phenotypic differentiation of cells (Guilak et al., 2009, Pek et al., 2010, 
Engler et al., 2006). For example, cell behaviour has been shown to vary between 2 and 3-
dimensional cultures and cell differentiation has been altered by the stiffness of the 
biomaterial being used (Kisiday et al., 2002, Pek et al., 2010). For this reason, there has been 
a great amount of interest in tools that enable the study of cell behaviour in 3-dimensions 
(3D).  
2.4.4 Tissue scaffolds in REPs 
As previously discussed, the PDC is a biphasic connective tissue with mineralised dentine 
supported by a central core of unmineralised dental pulp. Whilst there are a number of 
distinct differences between the two tissue types in terms of cellular content and ECM 
composition (Goldberg and Smith, 2004), type I collagen is the predominant protein. Natural 
polymers like collagen are therefore a popular choice of tissue scaffold in REPs. Despite 
providing the necessary supporting structure for cell attachment and growth, tissue scaffolds 
alone are inadequate for regenerative processes to occur. For complete pulp regeneration it is 
clear that the predominant cells of the dental pulp will be required, namely odontoblasts and 
fibroblasts. These cells can be pre-seeded or encapsulated within the tissue scaffold, or 
alternatively, progenitor cells or cell precursors that display multi-potency may be recruited 
into the root canal by cell homing strategies. Whilst a large number of studies have reported 
the application of tissue scaffolds into root canal systems, fibrin (blood clot) scaffolds 
remain the most widely used and are produced by deliberate mechanical trauma to the 
periapical tissues. The fibrin scaffold that results represents a reservoir of cytokines and 
ECM-proteins that can recruit cells and determine their fate in a process analogous to 
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general wound healing. Connective tissue in-growth of bone and cementum have been 
reported along with odontoblast-like cells (Shimizu et al., 2013, Shimizu et al., 2012), but 
true regeneration is yet to be demonstrated. Where exogenous scaffolds are used, their 
bioactivity and influence over cell recruitment is likely to be fundamental to success.  
Broadly speaking, tissue scaffolds in REPs can be categorised as injectable or pre-
fabricated/casted (Piva et al., 2014). The injectable materials are extremely convenient for 
endodontic practice, which frequently involves applications of irrigants and medicaments 
through hollow bore, small gauge needles. The most compelling attribute for injectable 
material technology relates to the ability of these materials to conform to the often highly 
irregular anatomy of the root canal system with seemingly little mechanical preparation 
required. However, the injectable nature of materials can restrict the control over the 
internal-architecture of the resultant tissue scaffold when compared with casted scaffolds, 
which can be produced based on pre-determined structural requirements e.g. pore size. In 
contrast, pre-fabricated scaffolds can be produced using conventional fabrication techniques 
or additive manufacturing that enables more precise control over porosity and 
interconnectivity. These conventional “casting” techniques, which were outlined earlier 
include porogen leaching, gas foaming and cryogelation, in which polymeric, macroporous 
materials are produced with fairly precise architecture. In the case of cryogelation, freezing 
of the biomaterial to sub-zero temperatures induces crystal formation of the solvent 
(commonly water), which is subsequently sublimated to leave the porous structure of the 
polymerised solute.  
Alternatively, additive manufacturing (AM), a branch of engineering that is rapidly 
expanding into the medical sector can be used to fabricate porous tissue scaffolds. The 
combination of AM strategies with three-dimensional imaging techniques such as cone-
beam computed tomography (CBCT) and magnetic resonance imaging (MRI), enables 
computer-aided segmentation and design tools to produce bespoke, custom-made medical 
devices from a wide range of materials. Titanium or Titanium/Zirconium Implants used in 
orthopaedic and cranio-facial applications have historically lead the field in this discipline. 
However, exciting advances are being made in extrusion technology-based systems such as 
fused deposition modelling (FDM) and electrospinning; photon-polymerisation techniques 
such as stereolithography apparatus (SLA) and digital light processing (DLP); and 
bioprinting technologies including inkjet printing and microextrusion.  
Despite these advances, the search for biomimetic ECM substitutes in pulp regeneration has 
focussed research on more conventional materials (Albuquerque et al., 2014), such as ECM-
derivatives like collagen, decellularized pulp (Alqahtani et al., 2018), platelet-rich fibrin 
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(PRF) (Shivashankar et al., 2012) and combination-scaffolds (Nosrat et al., 2019, Huang et 
al., 2018). The wide adoption of REPs in clinical practice has enabled a meta-analysis 
comparing the use of blood clot and platelet concentrates such as PRF, which reported 
improved outcomes for apical closure at 12 months when PRF was used (Murray, 2018). 
This suggests that the quest for improved bioactive materials for use in REPs is likely to lead 
to improvements in outcomes over conventional blood clot revascularisation techniques 
currently employed. In this scenario, these platelet concentrates that are centrifuged from 
autologous blood samples, represent a growth factor-laden fibrin clot that has demonstrated 
good wound healing properties through its chemotactic and angiogenic properties (Naik et 
al., 2013, Borie et al., 2015). Alternative materials have also been investigated that would 
not require venepuncture. The majority of these alternative materials are synthetic and ECM-
derived tissue scaffolds that represent a group of hydrophilic monomers referred to as 
‘Hydrogels’.  
2.4.5 Hydrogels in Regenerative Endodontic Procedures 
The use of numerous biological and biohybrid hydrogels in REPs was documented by 
Alberqurque et al. (2014) The vast number of hydrogels being studied reflects the rapidly 
expanding field of research into hydrogels for medical and dental applications (Van 
Vlierberghe et al., 2011). Peppas et al. defined hydrogels as, “three dimensional, 
hydrophilic, polymeric networks capable of imbibing large amounts of water or biological 
fluids” (Peppas et al., 2000). The injectable nature of this group makes them desirable in 
endodontics, as they can be stored in syringes and applied clinically in the same manner as 
general endodontic irrigants and medicaments (Murray et al., 2007). In their basic form, 
these natural materials are considered nanoporous, with a high water content (70-90%) that 
enables nutrient exchange by diffusion (Ikada, 2006). As a result of their high water content, 
single network hydrogels are weak with poor mechanical characteristics. As pulp 
regeneration occurs within the confines of the highly mineralised enamel and dentine, the 
lack of mechanical resilience may have little effect upon the performance of the hydrogel 
and may in fact offer distinct advantages due to their ease of application. However, in many 
tissue engineering applications, mechanical characteristics are fundamental to success, and 
as such combinations of hydrogel networks or hydrogels produced with multiple cross-
linking methods are also widely reported (Ma et al., 2016, Li et al., 2017, Lin et al., 
2015).The polymeric structure of hydrogels remain insoluble due to the production of 
chemical crosslinks or due to physical entanglement of polymeric fibres. Hydrogen bonding 
and van der Waals interactions have also been identified and discussed in greater detail 
elsewhere (Peppas et al., 2000, Van Vlierberghe et al., 2011).  
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The type of crosslinking, physical or chemical, can be used to classify hydrogels, along with 
numerous other strategies including their chemical structure e.g. peptide-based or their 
preparation method e.g. self-assembling/pH/temperature (Jonker et al., 2012). 
Polysaccharide and protein (peptide) hydrogels that have been discussed in a number of 
detailed reviews (Ricapito et al., 2016, Van Vlierberghe et al., 2011, Jonker et al., 2012), are 
composed of molecules present in homeostatic, metabolic processes that accounts for their 
low immunogenicity. In their basic form, protein hydrogels are fabricated from ECM 
derivatives such as collagen, gelatin and elastin. However, various synthetic peptide and 
hybrid peptide hydrogels have also been produced and reported in the literature (Jonker et 
al., 2012, Ricapito et al., 2016). These include self-assembling peptides that have been 
investigated both with and without progenitor cell encapsulation. Puramatrix™, a 
commercially available self-assembling peptide, is one such material widely researched that 
has a high water content (99%) and a fibrous structure with nanopores of 50-200nm scale.  
2.4.5.1 Collagen and Gelatin 
Collagenous proteins are the most abundant proteins in the human body. It is also the most 
common protein in the dental pulp, of which type I and III are most frequently encountered 
(Linde, 1985). Collagen is therefore a popular choice of biomimetic tissue scaffold for cell 
culture applications (Kreger et al., 2010) and REPs (Albuquerque et al., 2014, Nakashima 
and Iohara, 2014). Gelatin is a biopolymer produced from collagen. Hydrolytic degradation 
of collagen produces a polymer that is used in a wide range of pharmaceutical and food 
applications. As a biological polymer derived from mammalian organisms, it has been 
widely reported as a suitable biomaterial candidate in tissue engineering applications. 
Gelatin based hydrogels are highly biocompatible (Lai, 2010, Sung et al., 1999, Ulubayram 
et al., 2002, Yang et al., 2018) and can be easily modified to influence mechanical structure 
and biodegradability (Jaipan et al., 2017, Van Vlierberghe, 2016). Chemical cross-linking is 
required to avoid dissolution in physiological aqueous conditions at 37⁰C, due to the sol-gel 
transition temperature of approximately 30⁰C. A number of potential cross-linking agents 
have been identified (Liang et al., 2004, Sung et al., 1999, Van Vlierberghe, 2016), which 
are predominantly water-soluble. Carbodiimides are one chemical group shown to activate 
carboxylic acid residues on gelatin, which are subsequently attacked by amine groups to 
form short-range intermolecular crosslinks (Cammarata et al., 2015, Liang et al., 2004).  
2.4.6 Tissue scaffold challenges in REPs 
Whilst the clinical benefits of REPs are clear, the biological reparative/regenerative 
processes underlying them are not. Furthermore, whilst biomaterials may serve to improve 
the outcome or predictability of regenerative procedures, the requirements for any potential 
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tissue scaffolds are not understood. Whilst injectable technology seems practically and 
anatomically appropriate, little is available in the literature to compare one material from the 
next. Furthermore, understanding the effect of pore size and mechanical structure of the 
scaffold on the resultant cell phenotypes requires investigation. Research in the field of 
cancer invasion would suggest that hydrogels with pore sizes in the nano or micro scale will 
require enzymatic degradation for cells to be able to invade, which may restrict the speed of 
cell recruitment (Paul et al., 2017). In comparison, clinical studies using PRF have reported 
favourable outcomes for platelet concentrates that display internal pore sizes of less than 
1µm when fresh (Li et al., 2014). However, it must be stressed that clinical success is not 
synonymous with regeneration. The rate of new biological and bio-hybrid material 
development further serves to complicate this area, as basic research into the material-cell 
interactions can take several years to perform. Further material considerations such as elastic 
modulus and scaffold considerations such as porosity and interconnectivity require greater 
investigation to examine the effects of these parameters on a range of factors including cell 
migration, cell phenotype differentiation and ECM-production. Tissue/application specific 
research of the above factors is necessary to understand the requirements for pulpal 
regeneration.  
2.5 Progenitor Cell migration, proliferation and attachment 
2.5.1 Cell migration 
Cell migration is an imperative process for cell survival, repair and regeneration in many 
organisms. The critical role of cell migration for complex organisms is evident in a wide 
range of cellular processes such as gastrulation, neovascularisation, nerve sprouting, immune 
surveillance and wound healing (Trepat et al., 2012, Vicente-Manzanares et al., 2005). Cell 
migration has been studied extensively within biological processes and in vitro, as invasion 
of tissues by migratory cells is a therapeutic target in the prevention and management of 
cancer. In fact, the mere definitions of these two terms, migration and invasion, are critical 
when considering the parameters being investigated and the desired result from cell motility. 
Kramer et al. defined cell invasion as the movement of cells in 3D with the subsequent 
restructuring of the ECM (Kramer et al., 2013). In contrast, cell migration was defined as the 
“non-destructive, non-proteolytic movement of cells”. Ultimately, in the context of 
biomaterial research, the differences in the processes discussed within the above definitions 
are multi-factorial and this will inevitably have significant effects upon the outcome of 
studies investigating biomaterials in REPs. For example, the use of a non-invasive cell line 
in a nano-porous biomaterial could yield drastically different results in comparison to a 
highly migratory cell line seeded onto a macro-porous scaffold, as the ability to reorganise 
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the biomaterial would be fundamental to invasion. The type of cell and the size of the 
internal cellular organelles are also critical to cell migration/invasion, as different cells 
display different patterns of migratory behaviour and large cell nuclei can resist movement 
through small pore matrices in what has been coined the ‘nuclear limit’ (Paul et al., 2017). 
This very simplified example further reinforces the gravity of the challenges faced when 
assessing different biomaterials with different cell lines in different biomedical applications; 
as small changes in chemical or physical composition can have a significant impact upon the 
cell-matrix interactions observed. Furthermore, the primary objective for cell 
migration/invasion is dependent on the medical applications i.e. in cancer metastasis the 
primary objective is to impede cell metastasis, whilst for tissue regeneration, rapid cell 
migration would be desired.  
A wealth of information is available on topographical and molecular changes within cells 
during migration (Pollard and Borisy, 2003, Devreotes and Horwitz, 2015, Nagano, 2012). 
Studies on cancer metastasis have shown that cells possess a range of migratory techniques 
to enable movement and invasion of tissues (Paul et al., 2017). Whilst some cells may 
migrate individually e.g. leukocyte extravasation, some migrate collectively i.e. cell-cell 
adhesion is maintained e.g. epithelial wound healing. These migratory behaviours are 
influenced by the physical interactions between the cell and the ECM; the proteolytic 
activity of cellular enzymes; and a series of complex intracellular pathways (Trepat et al., 
2012). The ability of cells to polarize for directional migration is reliant upon internal 
modulation of the actin cytoskeleton to produce projections like lamellipodia and filopodia 
(Huttenlocher and Horwitz, 2011, Pollard and Borisy, 2003). Subsequently, focal adhesions 
and adhesion complexes that connect the intracellular cytoskeleton to the external ECM 
develop to enable the cell to gain traction (Parsons et al., 2010). The process of cell 
migration is inherently linked with these cell adhesions, which have been broadly classified 
as integrin and non-integrin mediated cell-substrate interactions (Huttenlocher and Horwitz, 
2011). Integrins are transmembranous receptors composed of αβ-heterodimers with specific 
ECM-binding profiles, of which the RGD sequence (Arg-Gly-Asp) appears to be the most 
frequently reported. The assembly and disassembly of these adhesions (adhesion turnover) is 
cell and ECM dependent, with more migratory cells associated with smaller focal adhesions, 
whilst sedentary cells on 2-dimensional substrates display larger adhesions (Vicente-
Manzanares et al., 2005). Furthermore, some ECM proteins display a greater array and 
number of integrin binding sites such as the aforementioned RGD motif, which can further 
influence migration (Trepat et al., 2012). 
A large amount of early research into cell adhesion and migration has focussed on 
fibroblasts (Chen, 1979, Abercrombie et al., 1970), which migrate via a process referred to 
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as ‘mesenchymal migration’ (Justus et al., 2014, Kramer et al., 2013). Fibroblasts are cells 
found in abundance in mesenchymal tissues such as dental pulp, where they contribute to the 
production and regulation of the ECM; most notably the synthesis of collagen. Fibroblasts, 
like other migratory cells, display a complex actin cytoskeleton that is heavily involved in 
cell polarity, focal ECM attachments and protrusion (Pollard and Borisy, 2003). Actin 
polymerisation is a critical cellular process involved in the protrusion of the cell’s leading 
edge through the associated ECM and it is these features that are characteristic of 
‘mesenchymal migration’ (Kramer et al., 2013). The actin rich projections that form at the 
leading edge of a migratory cell are referred to as lamellipodia, and within these projections, 
the actin cytoskeleton maintains a dynamic relationship with transmembrane cellular 
adhesion moieties such as integrins and syndecans. These transmembranous proteins and 
proteoglycans are interaction points between the advancing cell and the surrounding ECM. 
As mentioned above, turnover of these adhesion molecules is a contributory factor in the 
speed of cell migration, whereby smaller molecules can undergo faster assembly and 
disassembly for highly motile cells (Trepat et al., 2012). Whilst lamellipodia-based 
migration is well documented, other migration strategies have been reported (Petrie and 
Yamada, 2012).  
2.5.2 Methods of assessing cell migration in vitro 
Traditionally, the initial method for assessing cell migration was with 2-dimensional cell 
culture assays such as the scratch test (Liang et al., 2007). This simple strategy involved 
artificially creating a gap in an already confluent plate of cells using a standardised piece of 
laboratory equipment e.g. a P-200ul pipette tip. The cells were subsequently imaged using 
light or fluorescence microscopy to visualise the migratory behaviour of the cultured cells as 
they bridge the gap. Fluorescent labelling of target DNA enables further analysis of 
intracellular molecular up-regulation or suppression. This wound healing assay is similar to 
the cell exclusion zone assay, in which cells are cultured on tissue culture plastic that is 
divided by a removable insert. Following removal of the insert, a cell free zone remains into 
which cell migration can be observed and recorded. This strategy also allows for the addition 
of ECM protein hydrogels such as collagen or matrigel™ over the monolayer cultures, 
which enables the restrictive or inductive effects of matrix and/or growth factors to be 
assessed (Kam et al., 2008). This second strategy, synonymous with the circular invasion 
assay (circular cell free zone), produces a predefined space for improved consistency and 
reproducibility.  
Alternative methods to assess the effects of chemotactic agents on cell migration include the 
Boyden chamber or Transwell® migration assay (Boyden, 1962). The Transwell® assay 
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involves the culturing of cells within a tissue culture plastic insert, the base of which 
contains a polycarbonate track-etched membrane with pores of specific diameters and 
densities. The insert can divide a standard culture plate well into upper and lower 
compartments to enable an array of parameters to be assessed including growth factor 
profiles or different ECM composition. The transmigration of leucocytes through endothelial 
monolayers has also been assessed using the Boyden chamber design (Li and Zhu, 1999). As 
above, the coating of the insert with ECM components enables cell invasion to be assessed 
in what is termed the transwell® invasion assay (Marshall, 2011). The process of cell 
migration into or through ECM derivatives enters the realm of 3D cell invasion/migration 
assays, which more closely resembles cell behaviour in physiological and pathological 
processes.  
2.5.3 Methods of assessing cell migration in 3D 
It has been well reported that 2D monolayer cell cultures do not represent the true 
physiological behaviour of cells (Baker and Chen, 2012, Duval et al., 2017, Vanderburgh et 
al., 2017). Cell-cell and cell-ECM interactions are drastically different between the two 
types of culture and these changes alter cell phenotype and gene transcription (Wozniak and 
Keely, 2005, Sung et al., 2013, Bott et al., 2010, Martino et al., 2009). In order to 
circumvent these issues, the behaviour of cells in 3D cell culture has been studied via several 
different strategies. The seeding or encapsulation of cells into biopolymer hydrogels was 
reported over 30 years ago (Schor et al., 1983) and this methodology remains popular today. 
The imaging of cells in 3D culture has become more prevalent with the development of 
more advanced microscopy, such as confocal scanning laser microscopy. Cellular tracking 
dyes can be conjugated to specific proteins to enable real-time assessment of cell behaviour 
and protein translation.  
Despite these advances, the search for more biomimetic models in which to study cell 
behaviour at the tissue level has led to the development of organotypic cell culture models, 
in which the entire environment of the 3D model is focussed on replicating a specific organ. 
As such, spheroids and organoids are becoming frequently identified terms within the 
literature (Ranga et al., 2014) as they enable the various cellular and non-cellular 
components of the target organ to be studied with greater accuracy. These advanced 
strategies of 3D cell culture recognise the various roles played by each component of a 
living tissue and attempt to recreate this environment more biomimetically.  
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2.5.4 Cell migration assessment in REPs 
In regenerative endodontic procedures, several histological studies have been reported that 
are able to demonstrate cell migration into previously devascularised root canals 
(Albuquerque et al., 2014). These studies are proving pivotal in addressing the current dearth 
of literature relating to the actual biological tissues that are recreated when REPs are 
performed clinically. Through histological studies it is now clear that REPs performed in 
necrotic teeth display different reparative processes than those that have maintained some 
viable pulpal tissue (Shimizu et al., 2012, Shimizu et al., 2013). Whilst further ex vivo 
studies will continue to add to these findings, it is currently not clear how tissue scaffolds 
could influence the regenerative processes being undertaken and how the use of such 
biomaterials may influence or direct stem cell fate. Due to strict regulatory restrictions, it is 
exceedingly difficult to develop biomaterials for use in clinical scenarios and as such, 
clinicians instead often opt to use current medical devices and products with FDA approval 
(Chrepa et al., 2017).  
The use of extracted teeth to model REPs enables the dentine-pulp interface to be studied 
more closely. However, problems with collection, disinfection and processing of the teeth 
may arise. Furthermore, the extracted tooth model is low throughput and better suited for the 
study of optimised tissue scaffolds. As a result, an in vitro model that represents the possible 
dimensions of an intact root canal system would serve to increase the knowledge relating to 
tissue scaffold’s parameters and the role of the tissue scaffold in facilitating pulp 
regeneration. At the time of writing, no 3D model or organotypic model specifically for 
REPs could be identified to study cell migration and cell-ECM interactions in vitro. Whilst 
some commercially available 3D migration tools were identified e.g. CelluSponge™ 
(Merck, Dorset, UK), their design did not accurately replicate pulp regeneration. 
2.6 Additive Manufacturing Strategies 
Additive Manufacturing (AM) is now synonymous with a wide range of CAD/CAM 
processes, which includes rapid prototyping (RP), 3-dimensional printing (3DP) and solid 
free-form fabrication (SFF). AM acknowledges that the final object is produced in an 
additive manner and has been endorsed by the American Society for Testing and Materials 
(www.astm.org - ASTM International, Pensylvania, USA). AM enables a CAD file to be 
manufactured through a range of technologies, most of which involve the deposition of 
successive layers of a chosen material, which provides precise control over product 
geometry and architecture. The degree of precision and accuracy is dependent upon the 
technology being used and the materials that are available for each method. A wide range of 
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AM techniques have been developed and they have previously been classified into five 
categories based on the technology and material being utilised (Table 1) (Gross et al., 2014). 
These processes have developed significantly since 1986 when ‘Stereolithography’ was 
patented by Charles Hull (Schubert et al., 2014). This original process, also known as 
‘Stereolithography Apparatus’ (SLA), utilises ultra-violet light to photopolymerise resin 
monomer into a 3-Dimensional resin polymer. Originally used to print prototypes and 
models, this technology has revolutionised the production and engineering of components in 
many disciplines including the automotive and aeronautical industries. AM is expected to 
grow to become a $6 billion dollar industry by 2021 (Wohler's, 2013). In 2013, medical 
applications of AM were reported at only 1.2% of the entire industry; however, with greater 
advances in material science, medical applications are projected to account for 21% of the 
industry by 2023 (Schubert et al., 2014). 
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Table 1 Common additive manufacturing technologies and their properties 
2.6.1 Additive Manufacturing in Medicine and Dentistry 
AM has been investigated for use in a wide range of potential applications and encompasses 
a wide range of techniques (Table 1). In the medical field, customised prostheses, 
anatomical models and surgical guides are becoming more and more accessible (Ventola, 
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2014). One additional AM strategy gaining popularity in tissue engineering is ‘Bioprinting’ 
(Murphy and Atala, 2014). Bioprinting refers to the production of organic tissues or organs 
in a process which involves the automated, controlled deposition of cells and ECM in a 
predefined spatial relationship. Production of patient specific organs could have significant 
ramifications for the field of organ transplantation, which is currently oversubscribed and 
results in many deaths each year when a suitable organ donor cannot be located (Cui et al., 
2012). Whilst further investigation into the effects of bioprinting on mammalian cells is 
required, it is clear that these strategies will radically shape the future of healthcare, with a 
much greater focus on biomimetic, custom-made devices and personalised medicine.  
Additive manufacturing processes are rapidly advancing the field of dentistry and appear to 
be at the forefront of improvements in patient-centred outcomes as well as offering 
significant economic benefits from digitalising workflow and decreasing personnel costs. 
Anatomical models, prostheses (dentures and implants) and surgical guides can now be 
produced and it is therefore clear why concerns about the reduction in demand for dental 
technicians have been raised for some time (Battersby, 2014). Furthermore, finite element 
methods (FEM) is an alternative CAD/CAM process that can be used to analyse and assess 
prostheses to optimize their performance (Chen et al., 2015). Aside from the more global 
economic benefits of adopting AM, it is also being used to study the impact of scaffold 
architecture and surface topography on cell phenotype, which presents an additional facet of 





3 Materials and Methods 
3.1 General Materials 
3.1.1 Basic Materials 
Tissue-culture treated polystyrene culture flasks and plates were purchased from Merck 
(Dorset, UK). Non-treated (non-adherent) polystyrene tissue culture plates were purchased 
from StarLab Ltd (Milton Keynes, UK). Dulbecco’s Modified Eagles Media (DMEM – 
GlutaMax), Antibiotics (1% Penicillin-Streptomycin), Fetal Calf Serum (FCS)¸ gelatin from 
porcine skin (Gel strength 300g Bloom) and N-Hydroxysuccinimide (NHS) were purchased 
from Sigma-Aldrich (Dorset, UK). The carbodiimide, 1-(3-Dimethylaminopropyl)-3-
ethylcarbodiimide HCl (EDCI), was purchased from Carbosynth (Berkshire UK). Medical 
Grade Type I, bovine collagen was purchased from Collagen Solutions (Glasgow, UK) in 
3mg/ml and 6mg/ml concentrations. Additional laboratory equipment used was available 
within the Institute of Aging and Chronic Diseases (IACD) and will be discussed within the 
text. Where required, cells were fixed using 4% paraformaldehyde available from internal 
stock made within the IACD. Cells were permeabilized with 1% Triton™ X-100 for 
molecular biology, a non-ionic surfactant and emulsifier (Sigma-Aldrich, Dorset, UK). 
Nucleus staining was performed using 4′,6-diamidino-2-phenylindole (DAPI) either in 
solution, Invitrogen™ DAPI dilactate, or with mountant, ProLong™ Diamond Antifade 
mountant with DAPI (ThermoFisher Scientific, UK). Actin staining was performed using 
Invitrogen™ Alexa Fluor™ 647 Phalloidin, a high-affinity F-actin probe (ThermoFisher 
Scientific, UK).  
3.2 Cell lines, Cell Passaging and Cell Counting. 
For the purpose of model validation, rapidly dividing and easily cultured cells were utilised. 
These included immortalised L929 mouse fibroblasts (passage 14-22) (Earle et al., 1943) 
and MDA-MB-231 human breast adenocarcinoma (triple negative) cells (passage 20-25) 
(Cailleau et al., 1974) that were available in previous stock frozen within the IACD. 
Cryovials containing cells were removed from the freezer and placed immediately into a 
water bath at 37⁰C and observed closely until defrosted i.e. no visible ice crystals 
(approximately two minutes). The defrosted dimethyl sulphoxide (DMSO)/cell suspension 
was quickly added to 5ml of DMEM with 1% Penicillin-Streptomycin in a 15ml centrifuge 
tube before being centrifuged at 1500RPM for 5 minutes. All media and DMSO were 
removed from the centrifuged pellet and the cells were resuspended in 10ml of fresh 
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DMEM, 1% Pen/Strep and subsequently aliquoted into five T75 flasks containing 10ml 
DMEM 1% Pen/Strep.  
3.2.1 Cell passaging 
Cells were cultured in an incubator at 37⁰C with 5% CO2 and observed daily until sub-
confluency (80-90%) was observed using light microscopy. Cells were subsequently 
passaged by removing excess media and rinsing each flask with 4ml PBS before discarding. 
Each flask was then washed with 2ml of pre-warmed 1x Trypsin/EDTA solution (0.12% 
trypsin, 0.02% EDTA) to detach the cells from the fibronectin-treated polystyrene flasks. 
The flasks were returned to the incubator and visualised every minute until all cells has 
detached and were in solution (approximately 3 minutes). 4ml of DMEM with 10% FCS and 
1% Pen-Strep was subsequently added to each flask before transferring the solution to a 
15ml centrifuge tube. Each flask was rinsed with 4ml PBS to ensure that all cells were 
collected and added to the cell solution in the centrifuge tube. The cells were then 
centrifuged at 1500RPM for five minutes. The resultant supernatant was carefully removed 
and the pellet resuspended in 2ml of DMEM/10% FCS/1% Pen-Strep cell media per flask 
into which the cells were to be split i.e. one flask split into five flasks required 10ml of 
media (1:5). 2ml of the cell solution was then added to each new T75 flask and an additional 
10ml of DMEM/FCS/Pen-Strep cell media was added. Flasks were then labelled and 
returned to the incubator at 37⁰C with 5% CO2/air mixture. 
3.2.2 Cell counting using the haemocytometer 
Cell counting was performed using a cell haemocytometer and a Biorad TC20™ automated 
cell counter (Bio-Rad Laboratories Ltd, Hertfordshire, UK). A single T75 flask was removed 
from the incubator and cells detached from the flask using the same process described 
above. Briefly, 2ml of pre-warmed trypsin/EDTA solution was added to the flask and 
incubated for five minutes. 4ml DMEM/FCS/Pen-Strep cell media was added along with 
4ml PBS before the resultant cell solution was centrifuged at 1500RPM for five minutes. 
The supernatant was carefully removed from the pellet and resuspended in 1ml of cell 
media. 10µl of cell suspension was mixed with 10µl of Trypan Blue Exclusion Dye 
(ThermoFisher Scientific, UK). The 20µl solution was then transferred to the cleaned 
haemocytometer with glass cover slip. Cells were systematically counted using a phase 
contrast microscope and manual tally counter, with blue cells discarded as non-viable. The 
total cells counted within four squares of the haemocytometer were multiplied by the 
haemocytometer constant i.e. the volume within one 1mm2 (1 x 10-4/10,000) and the dilution 
factor (2), before being divided by the number of 1mm2 squares counted (4).  
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Total cells per ml = Total cells counted x dilution factor (2) x 10,000 
        Number of Haemocytometer squares counted (4) 
3.3 Design and Production of the ‘Culture Button Well’ (CBW) 
3.3.1 Initial Design Considerations (Culture Plate Measurements) 
The production of a root canal analogue was fundamental to this project. A root canal 
analogue would enable cell migration to be assessed for the specific function of pulp 
regeneration. Of greatest interest in REPs is the discussion surrounding a “critical apical 
diameter”, which is the hypothetical diameter below which REPs may be an unsuitable 
management strategy for the immature apex. This concept was first introduced in a seminal 
dental trauma paper from 1986 (Kling et al., 1986). This paper assessed the influence of 
clinical factors on spontaneous revascularisation of avulsed permanent central incisors and 
reported that revascularisation failed to occur when radiographic apex diameter was less than 
1mm, compared to diameters greater than 1mm. Extrapolating these findings, several studies 
have attempted to further investigate this concept, with the suggestion that 
neovascularisation into the vacant root canal system and subsequent nutrient exchange is 
compromised with smaller apical diameters (Fang et al., 2018). Whilst more recent studies 
have reported successful outcomes with apical diameters of less than 0.5mm (Laureys et al., 
2013), the apical diameter remains an important parameter that may function as a prognostic 
factor when deciding upon patient-centred clinical management. In line with current in vitro 
cell migration strategies an insert was required that would support biomaterial fabrication 
and cell culture, whilst introducing no detrimental effects upon any cells utilised. 
The initial design considerations for an in vitro cell migration model was the standard 6 well 
tissue culture plate (Figure 1).Whilst Transwell® inserts (Figure 1 Inset) would be an 
alternative strategy for assessing cell migration into a range of biomaterials, these inserts are 
not available in sizes that would approximate to the anatomy, or diameter, of a root canal 
system and so the ‘critical apical diameter’ could not be assessed. It was also hypothesised 
that alternative researchers developing pulp regeneration biomaterials would be able to 
fabricate materials in a range of sizes to match the insert designed. For this reason, an insert 
was designed and produced for in vitro experimentation using commercially available 




Figure 1 6 well plate for cell culture: Inset – 48 well Transwell® Insert for cell migration assays 
Depending upon manufacturer, the internal diameter and depth of a 6 well plate is 
approximately 35mm by 17mm. The upper well of the CBW was therefore designed with an 
external diameter of 30mm and an internal diameter of 25mm. A maximum height for the 
CBW was selected as 16mm to enable it to fit into a 6 well plate. From a design perspective, 
the CBW could be further subdivided into a 3mm upper compartment, or well, and a 12mm 
lower compartment containing the root canal analogues that would house the biomaterials 
being investigated. Extra space was created for media within the plates by designing the 
lower compartment with a square cross-section with a diameter of 18mm. Reducing the 
width of the lower compartment was also guided by the concept that it may be possible to 
image the root canal analogues through the side of the CBW, assuming the CBW itself was 
translucent and that thickness did not exceed approximately 1-2mm. Figure 2 displays initial 





Figure 2 Initial Hand Sketches of possible CBW designs: a) Formal Graph Pad sketches with measurements; b, 
c) Early Prototype designs following formulation of the research question; d) Magnified image of preliminary 
design from image 
 
3.3.2 Computer Aided Design 
Following the initial hand designs (Figure 2) the CBW was subsequently designed using 
software called 3-Matic™ from Materialise® (Leuven, Belgium). A two day training course 
took place at Cambridge University in June 2017, with approximately 50% of the course 
assigned to segmentation skills for computed tomography (CT) and magnetic resonance 
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imaging (MRI) and the remaining 50% focussing on the design and production of 
implantable, custom-made medical devices and surgical drill guides. In short, the design 
process requires a series of shapes (‘primitives’) to be created and appropriated before 
merging (‘boolean addition’) or subtracting (‘boolean subtraction’) the primitives from each 
other. Figure 3 shows the design process which essentially started with a flat cylinder (upper 
compartment - Figure 3a) and cube (lower compartment - Figure 3c). Cylinders representing 
root canal analogues were created in a range of diameters (1-5mm – Figure 3d shows 2mm 
diameter) and were subtracted from the lower compartment cube to create space for the 
resultant biomaterials. Due to the limited cross-sectional space of the lower compartment, 
larger diameter cylinders 4-5mm were present in smaller numbers (n=4) compared with 
small diameter cylinders (1-2mm) which could be manufactured in greater numbers (n=20).  
 
Figure 3 CBW iterative computer aided design using Materialise 3-Matic: a) upper compartment 30mm blank; 
b) Superimposed 25mm blank cylinder; c) primitive CBW design with upper cylinder and lower square; d) 5x5 
grid of 2mm cylinders which were subsequently subtracted from the blank CBW  
Following the initial design stage, the model was refined, smoothed and annotated using the 
software’s ‘Finish’ tools to facilitate the orientation and labelling of samples when in vitro.  
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3.3.3 Additive Manufacturing Strategies 
A number of additive manufacturing strategies were investigated. These included 
stereolithography (SLA), Digital Light Processing (DLP), Selective Laser Sintering (SLS) 
and MultiJet Printing (MJP). SLA/DLP remain the most widely used, commercially 
available AM strategies within dentistry. SLA and DLP both use a photo-polymerisable 
resin monomer, contained within a resin vat. As the monomer is in liquid form, traditionally 
these technologies require the product to be produced upside-down. The build platform is 
sequentially lifted from the resin, with each subsequent layer cured to the previous layer by 
the judicious and meticulous targeting of a single photon of UV light from a laser 
(Vanderburgh et al., 2017). SLA therefore requires the CAD-controlled laser to “sketch” out 
the entire layer prior to moving on to the next layer.  Comparatively, DLP technology 
enables an entire layer to be cured at one time through the use of a projector. For this reason, 
DLP technology can produce an item quicker than SLA. However, this speed can be at the 
expense of surface finish and part resolution, due to the subsequent scatter of the light from 
the projection. Post-production for both technologies involve separate wash and cure stages. 
The removal of excess, uncured monomer by washing in an ultrasonic bath takes place 
before an extended cure in an ultra-violet light cure box.  
 
Figure 4 First Additively Manufactured Culture Button Well: The first CBW fabricated using a Form 2® 
Stereolithography Apparatus (SLA) printer.  
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Figure 4 shows the first CBW printed using SLA within the School of Engineering, 
University of Liverpool. The device had a good quality finish and took approximately four 
hours to print. Some concerns regarding the presence of uncured resin-monomer remained, 
along with the slight opacity of the part once cured. For this reason MultiJet printing was 
investigated with a commercial company, CBM (Swansea, UK). MultiJet printing involves 
the bottom-up production of the part from a range of powdered materials such as photo-
curable resin or casting wax. CBM utilised a ProJet 3500 HD Max from 3D Systems (Rock 
Hill, South Carolina, U.S.A) to fabricate a CBW from their VisiJet Crystal polymer that is 
United States Pharmacopeia (USP) class VI, meaning that the material and it’s constituents 
are tested for biocompatibility to determine if any leachates are toxic (Figure 5). 
 
Figure 5 Prototype Culture Button Well fabricated using MultiJet Printing: The picture part was additively 
manufactured from a photocurable-resin powder. The internal cylinders were fabricated in a range of diameters 
and macro-porous internal scaffolds are partially visible within the channels.  
However, the material was opaque and again concerns were raised about the ability to image 
biomaterials in situ. Furthermore, the high quality surface finish of the MJP CBW came with 
an equally high price, which restricted the optimisation process of the CBW as fewer “trial” 
CBWs could be printed and cast aside if inaccurate or subsequently rendered obsolete.  
At this time, the Kulzer CaraPrint 4.0 (Figure 6) was investigated and purchased by the 
School of Dentistry as a 3D printer for model production and splint manufacturing. These 
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large items with limited surface detail are ideal for DLP technology as an adequate surface 
finish for a study model or occlusal appliance is easily attainable with DLP. This DLP 
printer was used to print the CBW in a process that took approximately 25 minutes per build. 
Multiple CBWs (4-5) could be printed with each build.  
This technology was therefore, quick and efficient for the purpose of this study and any 
possible reductions in surface finish were deemed inconsequential. Despite these 
improvements in cost and efficiency, DLP presented similar limitations to SLA in terms of 
uncured monomer and lack of translucency. For this reason, an alternative approach was 
investigated and utilised, Indirect Additive Manufacturing.  
 
Figure 6 Kulzer CaraPrint 4.0 Digital Light Processing (DLP) Printer 
3.3.4 Indirect Additive Manufacturing  
To circumvent any issues associated with leachable constituents from additively 
manufactured parts and to improve the optical properties of the CBW, an indirect AM 
strategy was considered. Indirect AM involves the CAD/CAM production of a part negative, 
into which addition cured polyvinylsiloxane (PVS), or polydimethylsiloxane (PDMS) can be 




Figure 7 Initial Indirect Additive Manufacturing Prototypes: a-c) Display the first prototype two part negative 
designed using multijet printing. a) Lower Negative part b) Upper negative part c) Combined two-part negative 
d) Addition-cured PVS poured into the lower compartment during material trials and design optimisation  
Materialise 3-Matic™ software was again used to produce a negative of the CBW in a 
similar manner to that discussed above. During this process the previously designed CBW 
was essentially deleted from a square blank and then the resultant part separated at 
appropriate points to allow the cast part to be removed. This iterative design process ran 
simultaneously with the material considerations discussed in chapter 3.3.5 – Addition-cured 
PDMS. Initially a two part design was produced (Figure 7). Following printing of this part, a 
number of PVS/PDMS materials were trialled (Figure 7d), but unfortunately, the large 
number of parallel cylinders (twenty) and the shear strength of the materials meant that it 
was difficult to retrieve the cast CBW from the negative without tearing or damaging the 
CBW. Figure 8 (a-d) documents the iterative process which occurred, including an initial 
trial of a 3-part negative, in which the lower negative split in two parts (Figure 8d). Despite 
this modification, tearing of the PVS was evident and for this reason the lower part of the 
negative was designed in three-parts that approximated together and which were held with 
cable ties (Figure 9a). Cone shaped locating jigs ensured the three parts fit accurately. The 
optimised negatives to fabricate the CBW can be seen in Figure 9 including the 3-part lower 




Figure 8 Negative Part Optimisation using various addition cured poly-vinyl siloxane and 
polydimethylsiloxane: a) Initial PVS in 2-part negative b) 3 different PVS sample trials within the 2-part 
negatives c) tearing of the PVS trials with attempted removal d) torn PVS within a modified 3-part negative with 
2 lower parts (note: smaller part of lower negative not visible in photo) 
 
Figure 9 DLP produced CBW Negatives: a) Lower 3-part negative with locating points visible b) lower 3-part 
negative approximated together c) completed 4-negative with upper lid to close off the internal chamber 
To simplify the production of the CBWs, each subsequent negative was designed and 
produced with four cylinders. This reduced the occurrence of tearing of the PDMS upon 
removal from the mould (Figure 8) and simplified the tissue scaffold production as only four 
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scaffolds could be produced in each CBW. As the number of cylinders within the CBW 
increased, it became harder to maintain the media within the upper compartment of the 
CBW and a greater amount of raw material was used in producing the tissue scaffolds. Four 
cylinders within each CBW was therefore the optimal number as it enabled CBWs with 
different diameter cylinders to each hold the same number; it facilitated removal of the cast 
CBW from the negative mould without tears or damage; and it also reduced the amount of 
wasted raw materials when experimenting with different ECM-derivatives during the 
fabrication of the tissue scaffold range.  
The finalised CAD/CAM process was as follows: 
1. CAD file was loaded onto cara Print 4.0  
2. Print plate was cleaned with 99% Isopropanol with a microfiber cloth 
3. The print cartridge was filled with light-polymerisable resin 
4. Print was commenced 
5. Printed components were carefully removed from the print plate using a plastic 
spatula 
6. Components were rinsed thoroughly with 99% Isopropanol to remove excess resin 
7. Components were placed in ‘Pre-clean’ 99% Isopropanol ultrasonic bath for three 
minutes 
8. Components were cleaned with pressurised air 
9. Components were placed in ‘post-clean’ 99% Isopropanol ultrasonic bath for three 
minutes  
10. Components were cleaned with pressurised air 
11. Components were placed in Kulzer UV-light cure box for five minutes on the top 
surface and five minutes on the bottom surface 
3.3.5 Addition-cured polydimethylsiloxane (PDMS) 
A series of translucent, addition-cured PDMS products were investigated from a number of 
different sources (Table 2). Whilst the optical properties of the clear PDMS were desirable, 
the shear strength of the material was important as materials with low-shear strength tended 
to tear. Initial experiments combined PDMS catalyst and base at appropriate concentrations 
in line with manufacturer’s guidelines.  
After a series of materials had been trialled, a product known to our laboratory group was 
proposed as a possible suitable material. The material had previously been utilised to 
produce stretch chambers to assess the influence of circadian rhythms on cells (Rogers, 
2019). As such, Elastosil® 601, a translucent, pourable, addition cured silicone (Part A and 
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B) was purchased from Wacker Chemicals Ltd (Bracknell, UK). As no detrimental effects of 
over-curing were identified, the documented curing times were doubled to ensure curing 
through the negative was complete.  
Initial attempts to allow the material to cure for 24 hours at room temperature resulted in 
voids as the PDMS was able to leak from small injection vents within the CBW negative 
that allowed air to re-enter. For this reason, the mould was secured in a small vice and 
immersed in a water bath at 70⁰C for40 minutes until the material was cured. Despite this 
accelerated cure, CBWs were produced with bubbles due to the mixing process of the 
constituent PDMS and the possible re-entry of air or water during the curing process. Two 
strategies were investigated to circumvent these issues. Firstly, to avoid the presence of 
trapped bubbles incorporated during mixing, the PDMS was placed in a vacuumed-
desiccator for twenty minutes prior to pouring. Whilst this method was reasonably 
successful at excluding bubbles, a second approach involved centrifuging the mixed PDMS 
prior to pouring, which rapidly produced the most homogenous and air-free mix. The second 
strategy utilized involved using an oven at 90⁰C to further accelerate the curing of the PDMS 
post-pouring. This strategy reduced the curing time to approximately 20 minutes and served 
to reduce the risk of PDMS leakage from the mould during curing. 
The finalized casting process was as follows:  
1. The three part lower negative was secured with cable ties.  
2. A light coating of petroleum jelly (Vaseline™) was rubbed onto the external aspect 
of the cylinders using a micro-brush to facilitate CBW removal post-curing.  
3. Elastosil 601 was mixed in a glass beaker at a ratio of 9:1 (A:B) 
4. The mixed Elastosil was transferred to a 50ml falcon tube and centrifuged at 
1000RPM for two minutes.  
5. Upper and lower negatives were loaded with Elastosil and lids positioned carefully 
upon their lower counterparts.  
6. The mould was secured in a table clamp and immediately transferred to an oven set 
at 90⁰C for twenty minutes. 
7. The clamp was carefully removed from the oven using oven gloves and cooled under 
cold running water.  
8. The resultant PDMS CBW was removed carefully with a small scalpel and the use 
of a high-pressure laboratory air-line. 
9. The CBW was rinsed with 99% Isopropanol and internal channels gently cleaned 




  Table 2 Commericially available silicones trialled during CBW fabrication 
3.3.6 Post-Production 
Following curing, the CBWs were carefully removed using a high-pressure, laboratory air-
line to help separate the PDMS from the mould. Small amounts of flash and excess in the 
injection vents were removed using a number 15 scalpel (Swann-Morten, Sheffield, UK). 
The PDMS CBWs were cleaned with a micro-brush and 99% Isopropanol to ensure that no 
residual resin-monomer or petroleum jelly (Vaseline™) remained. 
  
Material Supplier Reason for rejection 
Dow Corning® EI-1184 
Optical encapsulant 
Univar Ltd (Widness, UK) Poor shear strength/tearing 
Dow Corning® 3140 RTV 
coating 
Univar Ltd (Widnes, UK) Poor shear strength/tearing 





Univar SC (Tamworth, UK) Supply restrictions 





4 Development and Validation of the Culture Button Well 
for Regenerative Endodontic Tissue Scaffold Assessment 
The following chapter details a number of optimisation processes involved in validating the 
CBW as a useful in vitro tool to assess cell migration. Due to the range of biomaterials 
trialled and a number of issues that developed with handling/imaging the scaffolds the 
research presented does not follow chronological order but serves to detail the key 
milestones and issues that arose in relation to the CBW design. In brief, this chapter 
documents the four key aspects associated with validating the CBW, which are: fabricating 
cylindrical scaffolds in the CBW; material choice and their modifications; imaging 
considerations; and attempts at inducing migration.  
 
4.1 Fabrication strategies for tissue scaffolds within the CBW 
Due to the wide range of potential biomaterials that have been proposed and reported as 
possible tissue scaffolds in REPs, it was hoped that the CBW could be used to fabricate the 
scaffold cylinders in situ. This would more closely replicate the use of injectable technology 
during the clinical regenerative endodontic procedure. As the CBW had been designed with 
open ended cylinders to house the scaffolds, the scaffolds could subsequently be created 
using the CBW in an upright or inverted position. Prior to experimentation, the CBWs were 
boxed, autoclaved and stored appropriately, whilst glass cover slips and the upper 
component of the CBW negative were cleaned with 99% Isopropanol and sterilised for 10 
minutes per side using a UV-steriliser.  
4.1.1 The Inverted Fabrication Technique 
Using this technique, UV-sterilised 22mm glass coverslips (Agar Scientific, Stansted, UK) 
were placed into the upper compartment of the CBW and the CBW inverted and reinserted 
into the upper negative from which the inserts were cast (Figure 10). Any liquid hydrogel 
could subsequently be administered using pipettes and pipette tips or syringes with small 
gauge hollow-bore needles attached. UV-sterilised 16mm glass cover slips (Agar Scientific, 
Stansted, UK) could then be positioned on top to ensure consistent gels were produced and 
to reduce risk of cross-contamination whilst within the incubator. Figure 11 shows 6mg/ml 




Figure 10 A CBW with 4mm diameter internal cylinders inverted within the upper CBW negative 
 
Figure 11 An inverted CBW with 6mg/ml type 1 bovine collagen in situ: Note - 16mm coverslip to help reduce 
cross-contamination and to assist with consistent dimensions of the gels 
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4.1.2 The upright fabrication technique 
This technique is the reverse of the technique described above. It involved the positioning of 
a sterile 16mm glass cover slip onto the bottom of the CBW, which was initially held in 
place using a gloved finger. Following pouring of the hydrogel, the surface tension created 
held the glass cover slip in place and the CBW could be positioned within a 6 well plate. 
This technique enabled a small layer of excess hydrogel to be poured to link the four 
cylinders from above. This additional layer (Figure 12) served to maintain the positioning of 
the hydrogels during extended culture, which on occasions could sag, drain or slip out of the 
CBW.  
 
Figure 12 A 2mm diameter CBW with 6mg/ml type 1 bovine collagen: Note: additional collagen film linking all 
four cylinders to resist gravitational forces during cross-linking 
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4.1.3 Coating of cover slips with Bovine Serum Albumin 
In an attempt to avoid the hydrogels from sticking to the glass cover slips, they were soaked 
in 1% bovine serum albumin over night at 4⁰C. These cover slips were subsequently used to 
seal 6mg/ml collagen into the CBWs. As with previous experiments, the coating of cover 
slips did not appear to make the collagen cylinders more consistent in their shape, nor did it 
stop some of the collagen draining out of the CBWs following cover slip removal. As some 
cylinders had also previously gelled without the BSA coated coverslips, it was decided that 
optimising the collagen gelation process was the main priority and further coating of the 
coverslips was not pursued.  
4.2 Biological Hydrogels and their challenges 
A range of suitable biological hydrogels were sought in an attempt to validate the CBWs as 
a possible in vitro cell migration tool. Due to the abundance of collagenous proteins in the 
pulp, collagen and gelatin were the predominant hydrogels investigated. The latter of these, 
gelatin, has been well documented as a possible biological tissue scaffold (Koshy et al., 
2014, Van Vlierberghe et al., 2007) that is cheap to purchase and translucent, making it an 
ideal matrix for imaging cell migration.  
4.2.1 Crosslinking of Gelatin using Carbodiimide and N-Hydroxysuccinimide 
Gelatin from porcine skin (Merck, Dorset UK) was dissolved in pre-warmed distilled H2O 
on a magnetic stirrer at a temperature of 60⁰C. Initial trial experiments found concentrations 
in excess of 20% w/v gelled almost immediately and it was therefore impossible to add the 
cross-linking solution prior to gelation. Subsequently, 1g of gelatin was added to 10ml dH2O 
at 60⁰C using a magnetic stirrer. EDCI was dissolved in 5ml of dH2O to produce a 10mM 
solution. NHS were added to 5ml dH2O to produce a 4mM concentration solution. EDCI and 
NHS was combined and added to the gelatin to produce a 5% Gelatin-EDCI-NHS (XLGel) 
solution before syringing the solution into the CBW using the ‘inverted fabrication 
technique’. Figure 13 shows a 4mm CBW containing 5% Gelatin-EDCI-NHS hydrogels, the 
bottom right cylinder of which, has been intentionally extruded with a micro-brush for 
illustration purposes.  
4.2.2 pH-Crosslinked Collagen Hydrogels 
In addition to the hydrogels described above, gelatin’s parent protein collagen was also 
studied. As such, medical grade, type I bovine collagen was purchased from Collagen 
Solutions (Glasgow, UK) in 3mg/ml and 6mg/ml concentrations. This product is cross-
linked by increasing the pH with a buffer to the optimal pH of 7.4.  
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Following optimisation of the mixing ratio (9 parts collagen to 1 part buffer), a consistent 
gel was produced in a 7ml bijou flask. However, trying to replicate the same consistency 
within the CBWs met with great difficulty. Frequently, when removing the cover slips from 
the CBWs after polymerisation in the incubator, the hydrogels would drain out of the CBW. 
On occasions, some cylinders would polymerise and others would not, further highlighting 
the challenges of working with biological hydrogels that can display batch variability 
(Caliari and Burdick, 2016, Antoine et al., 2014). Furthermore, when consistent collagen 
cylinders were produced, extended culture in media often resulted in notable dimensional 
changes that resulted in the movement of the gels. Movement, shrinkage or swelling during 
the incubation period affected the integrity of the gels and the seal created within the CBWs. 
In these situations, media frequently drained around the gels into the lower compartment 
which made maintaining growth factor gradients problematic. Due to these challenges, 




Figure 13 A 4mm CBW with 5% Gelatin cylinders chemically crosslinked with EDCI (10mM) and NHS 




4.2.3 UV-Crosslinking of collagen hydrogels 
Due to the ongoing challenges with trying to maintain consistent collagen hydrogels in 
culture, UV-crosslinking was also attempted in addition to using the pH buffer. UV-
crosslinking has been reported to polymerise collagen without diminishing the bioactivity of 
the gel (Davidenko et al., 2016). When compared to chemical cross-linking, UV crosslinking 
reportedly preserves carboxylic residues that are important attachment sites for integrin-
matrix interaction (Davidenko et al., 2016). A ULP-CL1000 machine was used at a range of 
intensities and time periods. Despite a perceived benefit from investigating this strategy, 
UV-treated hydrogels did not demonstrate improved structural resilience and a number of 
possible factors were raised. Firstly, the upright fabrication technique allowed both ends of 
the cylinder to be irradiated, whilst the inverted fabrication technique could only be 
irradiated from one aspect due to the presence of the resin negative which may have 
restricted the penetration of UV. Secondly, the presence of glass coverslips, which remained 
in situ to protect against contamination, is likely to have reflected a large amount of the UV. 
Thirdly, it was unclear if the heat generated whilst in the cross-linker may have denatured 
the collagen. Furthermore, no rheology or chemical assessment was performed on the gels to 
inform if the UV-crosslinking provided any benefit over pH crosslinking alone. UV-
crosslinking is therefore included below for completeness, but the strategy requires much 
greater investigation and no conclusions can be drawn on the impact that the UV may have 
had upon the physical and chemical properties of the scaffolds as insufficient data are 
available at this stage.  
4.3 Biocompatibility of the CBW 
Previous experimentation with Elastosil 601 within our lab group had concluded that the 
addition-cured rubber was supportive for cell attachment and growth irrespective of 
protein/glycoprotein coating e.g. fibronectin (Rogers, 2019). This was confirmed following 
an experiment using the CBW and Human MDA-MB-231 cells.  
4.3.1 Methods 
6mg/ml collagen hydrogels were poured using the inverted pour technique into three CBWs 
with different diameter cylinders (4mm, 3mm and 2mm cylinders) and duplicated using 
collagen at 3mg/ml. The top right cylinder in each CBW was filled with Matrigel® (Corning 
Ltd – Life Sciences, UK) at a concentration of 3mg/ml and was intended for comparison as a 
positive control (See Figure 14). CBWs were placed in a UVP CL-1000 Crosslinker for 20 
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minutes at 0.45J/cm2 in an attempt to further cross-link the collagen gels (Davidenko et al., 
2016).  
2x105 MDA-MB-231 cells were seeded onto the upper surface of the CBWs in 400µl cell 
media and placed in the incubator for 1 hour to attach. Following this time period, the CBWs 
were gently rinsed with PBS. 1.5ml cell media was placed in the upper compartment and 
2ml of cell media with an additional 20ng/ml epidermal growth factor (EGF) was placed in 
the lower well before returning to the incubator. EGF was selected as chemoattractant for 
MDA-MB-231 cells, as blockade of EGF receptors (EGFR) expressed on the cells has been 
shown to inhibit cell proliferation and migration (Hsieh et al., 2013, Prasad, 2009). Media in 
the upper compartment was changed daily until the end point of 72 hours.  
4.3.2 Results 
Unfortunately, all of the 3mg/ml collagen along with the 4mm and 2mm diameter 6mg/ml 
collagen cylinders failed to polymerise adequately and the hydrogel drained out of the CBW 
when the cover slip was removed and the CBWs reverted to their upright position. Wells A1, 
A3, B1, B2 and B3 from Figure 14 were therefore removed. Well A2 contained the only 
CBW that was seeded with cells and subsequently processed. However, by 48 hours it was 
clear that the collagen cylinders had dramatically reduced in size and length and the media 
added to the upper compartment was rapidly draining through the collagen cylinders into the 
lower compartment. At 72 hours the CBW was rinsed with PBS and soaked in 4% 
paraformaldehyde for 12 hours. This was subsequently removed and cells were 
permeabilised in 0.1% Triton-X for 20 minutes and stained with DAPI (1 in 10,000) for 1 
hour. Following processing, no consistent collagen cylinders remained and imaging of these 
cylinders was abandoned. Figure 15 shows the resultant confocal microscope image of the 
top of the CBW (i.e. the surface cells were seeded onto) at the periphery of the single 
remaining 3mg/ml matrigel cylinder, which was partially intact. This image clearly shows 
the MDA-MB-231 cells well attached to the CBW that was not coated prior to cell seeding. 




Figure 14 Diagram representing the Collagen/Matrigel CBW experiment. Only collagen in well A2 
polymerised adequately and within this well only the 3mg/ml Matrigel cylinder maintained viability throughout 
the 72 hour culture period. 
4.3.3 Discussion 
It was unclear whether the matrigel cylinder was damaged during processing or whether the 
cells preferentially attached to the Elastosil 601 material, but no cell migration into the 
matrigel was noted and limited cell attachment was visualised. As cell attachment to 
matrigel would be expected, it is more likely that the delicate matrigel cylinder was 
disturbed during processing. Figure 15 further highlights the difficulties faced imaging the 
hydrogel cylinders, as the cells visible on the matrigel cylinder are out of focus. The 
hydrogels frequently changed position in the mould during culture and also displayed a 
meniscus meaning multi-plane images were required to visualise the surface of the gels. No 
conclusions could be drawn as to why the gels in well A2 were more consistent than the 




Figure 15 Zeiss i3 Spinning Disk Confocal Image of the upper surface of the 3mg/ml Matrigel cylinder. The 
right half of the image displays the MDA-MB-231 cells attached to the Elastosil rubber of the CBW, whilst the 
left half of the image displays the 3mg/ml Matrigel cylinder. The dashed line represents the boundary between 
the two materials, with greater cell numbers on the Elastosil Rubber compared to the Matrigel. Arrows to the left 
of this line show a small number of cells visible compared to the densely populated area to the right of the 
dashed line. 
 
4.4 Imaging of hydrogels within the CBW 
It was clear from working with both collagen and gelatin, that hydrogels can be produced 
within the CBW. In addition, the rigidity of the 5% Gelatin/EDCI/NHS cylinders enabled 
the cylinders to be removed, processed and imaged separately. However, it would be highly 
desirable for the CBW to be designed so that imaging and live cell imaging could occur 
without removal of the scaffolds. For this reason, experiments were performed to assess the 
ability of a spinning disc confocal microscope (Courtesy of Tobias Zech – Institute of 
translational medicine, Liverpool University) to image scaffolds within the CBW.  
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4.4.1 6mg/ml collagen scaffolds pre-seeded with fixed MDA-MB-231 within the CBW 
In order to assess the design of the CBW on the feasibility of direct imaging of cells, the 
following experiment was performed: MDA-MB-231 cells were harvested and counted 
using a biorad TC20™ automated cell counter, with 2x106 cells removed in 448µl of cell 
media and mixed with 50µl of 37% paraformaldehyde for 7 minutes before centrifuging. 
Cells were subsequently permeabilised in 0.1% Triton-X solution for 7 minutes and 
centrifuged before being resuspended in PBS and DAPI (1 in 7500) for 20 minutes before 
centrifuging. The fixed and stained cells were re-suspended in 240µl of collagen buffer, 
which was mixed with 1.8ml of type I bovine collagen. This resultant fixed cell-collagen 
suspension was syringed into 3mm and 4mm CBWs with glass cover slips on each end and 
incubated for one hour prior to being imaged using the Zeiss i3 spinning disc confocal 
microscope at 10x magnification.  
Figure 16 shows a single slice of the subsequent Z-stack images that were recorded. As the 
coverslips were not removed from the gels prior to imaging, the collagen gels retained their 
shape and structure and imaging to a depth greater than 1mm was possible. During imaging, 
it became apparent that the microscope utilises two stages, a 300µm fine-focus stage that 
enables Z-stacking over a short distance and a larger, main stage that can enable imaging in 
the Z-axis to the maximum length of the lens. Whilst it was possible to record multiple 
300µm stacks within the gel, it was not possible to combine the smaller 300µm stacks 
together due to a technical issue with the software that communicates between the two 
stages. Appendix A (PDF Copy) shows a 300µm stack of the MDA cells pre-seeded within 
the collagen gels. Whilst no accurately defined length of imaging could be recorded, the 
ability to successfully image multiple 300µm sections throughout the gel suggested that the 
predominant factor that would limit the length of cell imaging was the working distance of 
the microscope lens. As the Zeiss i3 microscope has a working distance of 5mm, two key 
conclusions were made:  
1. The current design of the CBW with 12mm hydrogel cylinders was too long to 
image in its entirety. Inverting the CBW and imaging both ends would allow for a 
maximum depth of approximately 10mm, but concerns were raised regarding the 
splicing together of the two sections when imaged from different ends. As such, 
with the exception of purchasing a different microscope lens, a maximum length of 
5mm would be considered a more realistic length for imaging.  
2. With the current design, the distance between the hydrogel and the overlying cover 
slip must be minimised to ensure that there is no wasted imaging space. Desiccation 
or swelling of the gels when incubated could result in a large gap between the lens 
50 
 
and the top of the gel. This gap would reduce the total amount of the gel that could 
be imaged.  
 
 
Figure 16 6mg/ml collagen hydrogel containing MDA-MB-231 cells imaged within a 4mm CBW. (Note: single 
slice taken from video) 
Following this imaging session and further informal collagen experimentation, a decision 
was made to only use the 2mm CBWs for future experiments as collagen poured in 4mm 
and 3mm CBWs rarely had adequate surface tension or support to survive extended culture. 
The collagen when poured in the larger diameter cylinders would frequently be disrupted 
during removal of the coverslip and with addition of media.  
4.5 Migration Experiment 1 - 6mg/ml collagen hydrogels with L929 
Fibroblasts  
Following the initial attempts at imaging, it became clear that migration into the collagen 
hydrogels could be visualised using the imaging strategy outlined above without removal of 
the gels from the CBW. Whilst some issues were highlighted regarding the length of the 
gels, an experiment was performed utilising the same 6mg/ml collagen cylinders.  
4.5.1.1 Methods 
Firstly, four 2mm CBWs were cleaned with 70% Ethanol and autoclaved. Collagen was 
poured into two CBWs using the upright fabrication technique with the remaining two 
CBWs poured using the inverted technique. To further investigate the role that UV cross-
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linking may have upon the stiffness of the collagen hydrogels, one CBW from each 
fabrication technique arm were treated with 0.45J/cm2 UV light for a total of 30 minutes, 
whilst the remaining two CBWs not treated with UV light were given an additional 30 
minutes in the incubator.  
CBWs were subsequently transferred to a non-coated 6 well plate and cover slips were 
removed carefully with sterile tweezers. Cell media was supplemented with 10% FCS, 1% 
Pen-strep and 2% L-Glutamine for use in the lower compartment, whilst the same 
combination without FCS was utilised for the upper compartment. 2x106 L929 fibroblasts 
were harvested and counted using the biorad TC20™ automated cell counter and seeded 
onto the upper compartment of all four CBWs. 20ng/ml of EGF was added to the lower 
compartments, which along with the FCS was intended to act as the chemoattractant for cell 
migration. The 6 well plate, which is diagrammatically represented in Figure 17, was 
transferred to an incubator at 37⁰C with 5% CO2/air mixture. Media was changed at 24 hour 
intervals until the end point of 72 hours was reached.  
At 72 hours, the media was removed and the CBWs were gently rinsed with PBS. Cells were 
subsequently fixed by adding 4% PFA solution to the upper and lower compartments and 
left at -4⁰C for 12 hours. PFA solution was then carefully removed and 0.1% Triton-X 
solution was placed in the upper and lower wells for 20 minutes before the CBWs were 
gently rinsed with PBS. Staining of cells took place by using Invitrogen™ Alexa Fluor™ 
647 Phalloidin (Life Technologies Ltd, Paisley, UK) at 1x concentration (25µl 40x solution 
in 1ml PBS) for 1 hour before gently rinsing with PBS. Finally, the CBWs were soaked with 
2ml of PBS containing Invitrogen™ DAPI dilactate (1 in 4000) for 2 hours. Cover slips 
were repositioned in the upper compartment of the CBWs before imaging took place. 
4.5.1.2 Results 
At 48 hours, cells were visualised on the bottom of the 6 well plate in wells B2 and B3, 
whilst wells A2 and A3 did not, suggesting that the collagen seal within the CBWs remained 
intact for the CBWs poured using the upright fabrication technique. Visually at 72 hours, the 
collagen hydrogels in well A2 (without UV) seemed the most consistent, but all CBWs 





Following fixation and staining, it was apparent that CBWs in wells B2 and B3 were 
incomplete. Due to a large gap between the coverslip and the residual gel, no imaging could 
be recorded. CBWs from wells A2 and A3 displayed viable cell growth on the upper surface 
of the collagen hydrogels. Figure 18 shows an orthogonal reconstruction of a Z-stack series 
of images taken of the top of a collagen hydrogel in well A2. The curvature of the cell plane 
represents the meniscus formed by the hydrogel following pouring. Despite cell attachment 
and growth, no migration was evident. Figure 19 shows montage Z-stack images of the 
upper surfaces of collagen hydrogels from wells A2 and A3. Again, whilst these images 
demonstrate the concavity created naturally due to the meniscus of the gel, there was no 
clear migration demonstrated on any of the cylinders imaged.  
Figure 17 Diagram of ‘migration experiment 1’. 2mm CBWs with collagen hydrogels fabricated using the upright (Row 




Figure 18 Orthogonal Reconstruction of Z-stack images of the upper surface of a 2mm diameter, collagen 
hydrogel (Well A2) stained for Actin (Red) and DAPI (Green). The image has been reconstructed from a series 
of individual slices to show the top of the collagen hydrogel from a lateral position. Note the evident curvature of 
the cell plane depicted by the dashed line, which is due to the meniscus created when pouring the collagen 
hydrogel. This dashed line represents the top of the gel, where cells appear to have attached and proliferated on 
the superficial surface with no clear migration into the collagen hydrogel seen (below dashed line). The overall 
depth of gel visualised measures approximately 70 microns. Migration into the gel would be seen as clear cell 
penetration towards the bottom surface of the image. 
 
Figure 19 Z-Stack Montage of L929-Fibroblast cells on 6mg/ml collagen hydrogels: Each montage displays 11 
images (Left to Right) of subsequent 5µm slices from the lowest point (Left) to the highest point (right) stained 
with DAPI (Cyan) and Phalloidin (Magenta). Top = Collagen Gel from well A2. Bottom = Collagen Gel from 
Well A3. 
4.5.1.3 Discussion 
Aside from the continued issues relating to collagen gel consistency and integrity, three 
further issues were raised following this experiment. Firstly, and most fundamentally, no 
migration was evident into the collagen gels. Three possible factors could have accounted 
for this: 
1. No growth factor gradient was detectable by the L929 fibroblasts due to the length 
of collagen cylinders.  
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2. The collagen hydrogels at 6mg/ml were too stiff for the fibroblasts to invade into or 
a longer time period in culture would be required.  
3. The cell line utilised at passage 14-20 may have lost their capacity to invade.  
The issue relating to the length of the collagen gel and a possible lack of chemoattractant 
gradient seems plausible. As growth factors were added to the lower compartment, unless 
the chemoattractants were imbibed into the gels and wicked upwards, it is unlikely that the 
cells would have been able to sense the chemotactic agent present. This issue could be 
circumvented by pre-mixing chemo-attractant into the gels or by shortening the length of the 
gels altogether. As previous imaging issues have already highlighted the excessive length of 
the gels, this finding further reinforces the recommendation that the CBW should be 
redesigned with a shorter cylinder length to increase the likelihood that chemoattractants 
will be detected by cells. Furthermore, for revascularisation of the dental pulp to become a 
predictable strategy it is highly probable that strong chemoattractant profiles will be 
required. As part of this requirement, the liberation of dentine sequestered growth factors 
and their effects upon cell proliferation and expression has gained traction in the pulp 
biology literature (Tomson et al., 2017). With this in mind, the CBW could enable multiple 
chemoattractant profiles to be investigated in great detail and as such, optimising the length 
of the cylinders for this purpose seems an important and logical consideration.  
To investigate the second issue outline above, a further experiment was performed to assess 
the ability of L929 fibroblasts to migrate into 6mg/ml collagen, whilst the third issue could 
be investigated with human primary cells following CBW optimisation.  
 
4.6 L929 Fibroblasts and MDA-MB-231 cell exclusion zone assays with 
6mg/ml collagen 
In order to assess the ability of the chosen cell lines to invade into the collagen hydrogels, a 
cell exclusion zone assay was performed utilising L929 fibroblasts and MDA-MB-231 cells. 
Whilst it is clear that migration and invasion assays associated with monolayer cell cultures 
are not representative of the complex cell-matrix interactions witnessed in vivo (Baker and 
Chen, 2012, Duval et al., 2017), these experiments are quick to perform and provide a large 
amount of information about the speed of migration and possible strategies for optimising 
the matrix bioactivity. In these experiments, no additional cytokines were added to the 
collagen matrix, but prior to further experimentation, L929 fibroblasts were transduced with 
a green fluorescent protein (GFP) to enable imaging of cells in the CBW without requiring 
fixation and staining.  
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4.6.1 Viral transduction of L929 fibroblasts with a green fluorescent protein 
Stable GFP expression was introduced to the L929 fibroblasts via lentiviral mediated 
plasmid transduction. The cytomegalovirus-driven plasmid, pGIPz, also expresses 
puromycin resistance, which allows antibiotic selection of the L929 fibroblasts expressing 
eGFP. Cells expressing fluorescence can subsequently be imaged and monitored in 
prolonged culture without additional staining. Firstly, 5x104 L929 fibroblasts were seeded in 
6 well plates and allowed to reach subconfluency. 120µl of lentivirus (OriGene, Herford, 
Germany) was added to 6ml of DMEM into which 3µl of Polybrene® (Hexadimethrine 
bromide) was added (Polybrene stock 12µg ml-1/working solution 6µg/ml). Polybrene® 
serves to facilitate the transduction of the virus into the cells by modifying cell surface 
electrical charge. 1ml of this solution was added to each well and left overnight.  
Antibiotic selection for eGFP-expressing cells was performed using puromycin (GibCo, Life 
Technologies Ltd, Paisley, UK), an aminonucleoside antibiotic that inhibits translation of 
proteins. Puromycin selection involves the optimisation of the antibiotic concentration, 
which was performed using the following technique. Firstly, media containing the lentiviral 
particles were removed from the subconfluent L929 fibroblasts and cells were gently rinsed 
with PBS. Puromycin stock 500µg/ml was diluted 250x to produce a working solution of 
2µg/ml and 2ml of media containing different concentrations of puromycin were added to 
each well in duplicate (Figure 20) and cells were imaged after 24 hours.  
At 24 hours, there was limited expression of GFP and no clear selection for transduced cells 
was evident. For this reason, the same experiment was repeated with greater concentrations 
of puromycin. Puromycin was reconstituted from stock to produce a working solution of 
2.5µg/ml (5µg in 2ml). Increasing concentrations were trialled and cells imaged after 24 
hours (Figure 21). Following 24 hours, a puromycin concentration of 20µg/ml appeared 
optimal for selection of transduced cells and this concentration was added to all four wells 
and refreshed with media changes every 48 hours for 7 days. At this point, cells were 





Figure 20 First Puromycin Selection of lenti-virus tranduced L929 fibroblasts 
# 
 
Figure 21 Second Puromycin Selection of lenti-virus tranduced L929 fibroblasts 
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4.6.2 Cell Exclusion Zone Assays 
4.6.2.1 Methods 
Cell exclusion zone assays were performed using both cell lines available – GFP-L929 
Mouse fibroblasts and triple negative Human Adenocarcinoma Cells (MDA-MB-231). 
Sterile 2 well, silicone inserts with a defined cell free zone of 500µm (Ibidi GmbH, 
Gräfelfing, Germany) were positioned in the centre of a 24 well plate using sterile tweezers. 
3x104 cells from both cell lines were harvested in 80µl of media and seeded into both 
chambers of the inserts in duplicate. Cells were incubated overnight in 37⁰C with 5% 
CO2/air mixture allowing them to double in number and reach subconfluency. After 24 
hours, silicone inserts were removed and the wells gently rinsed with 1ml of sterile PBS. 
6mg/ml medical grade, type I, bovine collagen was prepared as per previous experiments 
using a sterile buffer and 100µl was poured into each well to cover the remaining cell 
monolayer. Cells were incubated and imaged overnight for 16 hours using the Carl Zeiss 
ApoTome Inverted Microscope. 
 
Figure 22 Cell exclusion zone assay with GFP-L929 Fibroblasts coated in 6mg/ml type 1, bovine collagen. Left 
- 0 hours. Right - 16 hours. 
4.6.2.2 Results 
Figure 22 displays the start (0 hours) and end (16 hours) time points for the migration assay 
using GFP-L929 fibroblasts. Whilst cell growth and division were evident, no clear invasion 
into the 6mg/ml collagen was seen. Figure 23 displays a bright field image with equivalent 
time points for the MDA-MB-231 cell line, which is a known invasive adenocarcinoma cell 
line (MacDonald et al., 2018, García et al., 2016). Appendix B (GFP-L929) & C (MDA-
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MB-231) show the video sequences for the two assays respectively (PDF Copy). Progressive 
migration is evident from both sides of the 500µm gap, which by the end point of 16 hours 
had reduced by approximately 50%.  
 
Figure 23 Cell exclusion zone assay with MDA-MB-231 adenocarcinoma cells coated in 6mg/ml, type I, 
bovine collagen. Left - 0 hours. Right - 16 hours. 
4.6.2.3 Discussion 
Following the cell exclusion zone assays, it was clear that the L929 fibroblasts utilised in 
‘migration experiment 1’ were unable to invade into the stiffer 6mg/ml collagen hydrogels 
over a 16 hour time period. Therefore, for the purpose of validating the CBW as a 3D 
migration/invasion tool, the more aggressive MDA-MB-231 cells appeared to represent a 
more desirable cell line. However, these cells do not represent a relevant cell line 
encountered in pulp regeneration. Whilst the L929 fibroblasts failed to migrate within 
migration experiment 1, it could be argued that the addition of chemotactic growth factors in 
the collagen hydrogels could influence the L929 fibroblasts migration or that primary cells 
may retain a more migratory phenotype.  
Despite the known aggressive nature of the adenocarcinoma cell line, invasion into the 
6mg/ml collagen was slow at a rate of approximately 100-150µms in 16 hours. As no 
attempt was made to characterise the architecture of the collagen hydrogel, it is unclear how 
the microchannels formed within the 3D collagen meshwork will have restricted or inhibited 
the speed of cell progression (Paul et al., 2017). The study of scaffold porosity and 
interconnectivity along with material characteristics such as linear and non-linear elasticity 
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is an extremely exciting and interesting field for tissue engineering (Doyle et al., 2013). 
Previously, 3D collagen gel elasticity has been shown to influence the migratory behaviour 
of cells from lamellipodia-based to lobopodia-based migration, that is mediated by RhoA-
ROCK-myosin II activity (Petrie et al., 2012). Further study on the mechanical 
characteristics of scaffolds and their impact upon cell migration is required.  
This slow invasion noted (Trepat et al., 2012) above has highlighted that the previous end 
point of 72 hours for the CBW migratory experiments is likely to be inadequate when 
considering the clinical challenge faced with pulp re-vascularisation. A vacant pulp canal 
space of 12mm, whilst long, would not be considered excessive for complete pulpal 
regeneration and as such the bioactivity and topography of the tissue scaffolds would likely 
require modification to facilitate and accelerate cell migration i.e. through the development 
of macro-porous scaffolds. Unfortunately, extended culture beyond 72 hours with the current 
collagen formulation in the CBWs was unpredictable, as the gels would often lose position 
and slip out of the cylinders. This therefore raised three further issues that require 
consideration when redesigning the second generation CBW.  The first consideration relates 
to maintaining the position of the hydrogels within the CBW for extended cultures. In this 
regard, redesigning the internal cylinders of the CBW as cones, with a slight taper towards 
the inferior end may help to retain hydrogels in situ during prolonged culture. The second 
consideration relates to the tissue scaffolds themselves and how modification of the 
scaffolds may facilitate cell migration and nutrient exchange. In this regard, fabrication of 
macro-porous hydrogels would provide internal channels for cell movement and nutrient 
exchange. Thirdly, the addition of growth factors or growth factor gradients to the 
hydrogels, may serve to encourage cells to migrate more readily into and through the entire 
gel. 
4.7 Dye-Leakage Trial with Bromophenol Blue and 1% Agarose 
Hydrogels 
To assess the ability of hydrogels within the CBW to maintain the “seal” of the upper 
compartment, bromophenol blue, a dye with a small molecular weight (669.96g/mol), was 
added to the top of 1% agarose hydrogels in the CBW. This further served the purpose of 
assessing how easily growth factors could be added to these hydrogels and how quickly the 
molecules would be expected to permeate through the gels. It also confirmed that consistent 
hydrogels can be produced using the inverted fabrication technique described earlier (4.1.1). 
It is well understood from electrophoresis experiments that the water content and density of 
the gel will fundamentally affect the degree of dye penetration. For this experiment, 1% 
agarose hydrogels were produced by mixing 0.5g of agarose powder (GibCo, Life 
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Technologies Ltd, Paisley, UK) in 50ml of PBS before heating until all powder was 
dissolved. Gels were syringed into 4mm CBWs and allowed to cool for 20 minutes until 
fully set.  
 
Figure 24 Bromophenol Blue Dye on 1% Agarose Hydrogels in a 4mm CBW 
 
Figure 24 displays 400µl of bromophenol blue dye on a 4mm CBW with 1% agarose gel 
cylinders (poured using the inverted fabrication technique). 400µl was considered the 
optimal volume of fluid that could be pipetted onto the CBW in the inverted position, 
without leakage over the side. This technique and volume could be used to seed cells onto 
the bottom of the CBW before reverting the CBW and adding growth factors into the upper 
compartment. This supported the concept that the CBW could be used as a bidirectional in 
vitro tool. Figure 25 shows 1% agarose hydrogels removed from the CBWs after 3 hours of 
Bromophenol blue coating. Whilst a fairly crude strategy for introducing growth factor 
gradients, it presents a different facet for the CBW as a tool that can also investigate 
different growth factors gradients. It further confirms that well adapted hydrogels will 
maintain an adequate seal for fluid in the upper compartment. As 1% agarose appeared 
significantly stiffer than the 6mg/ml collagen trialled, this further suggested that alternative 







Figure 25 1% Agarose Hydrogels (Seen in Figure 24) removed after 3 hours of bromophenol blue application 
to the top surface of the gel. Inset bottom left shows the 12mm gels sliced (~1mm) demonstrating penetration of 
bromophenol blue through the entire gel). 
4.8 L929 Mouse fibroblasts cultured on EDCI-NHS crosslinked gelatin 
cryogels 
4.8.1 Cryogelation of carbodiimide-crosslinked gelatin as a potential tissue scaffold for 
the CBW 
In an attempt to improve the degree of migration into the tissue scaffolds being investigated, 
macro-porous hydrogels were investigated. Whilst numerous strategies are available for 
producing porosity in hydrogels, cryogelation or ice templating was the first to be trialled in 
this study. The process of cryogelation involves the rapid cooling of an aqueous solution to 
temperatures below zero. During this process, ice-crystals form within the semi-frozen 
solution, which concentrates the solutes into a smaller volume referred to as the non-frozen 
liquid micro-phase (NFLMP) (Van Vlierberghe, 2016, Van Vlierberghe et al., 2011). 
62 
 
Subsequent sublimation of the solvent in these frozen gels removes water to leave a porous 
and interconnected scaffold structure. When these hydrogel constituents are treated with 
appropriate crosslinking agents, the NFLMP maintains its highly macroporous structure that 
can be used in a range of biomedical applications. Since gelatin undergoes a very rapid 
physical gelation process upon cooling, it has been reported that a true “cryotropic” gelation, 
i.e. one where ice crystals form within the solution prior to physical gelation, is impossible 
with concentrations of 10% w/v and above (Van Vlierberghe, 2016). 5% w/v gelatin was 
subsequently used in the following experiments, with chemical crosslinkers EDCI and NHS 
added to the solution prior to freezing.  
4.8.2 Methods 
4.8.2.1 Cryogelation and Sublimation of 5% Gelatin-EDCI-NHS hydrogels.  
A 5% Gelatin-EDCI-NHS (EDCI - 10mM/NHS - 4mM) solution was produced (section 
4.2.1). The solution was immediately pipetted using pre-warmed pipette tips into the 
following receptacles: 
• 3 x 50mm Petri dishes (4ml in each)  
• 600µl of solution syringed into a 4mm button well 
Following pouring, the samples were immediately transferred to the following freezers 
for cryogelation: 
• 2 x 50mm Petri dishes inserted in a -20⁰C freezer 
• 1 x 50mm Petri dish inserted in a -80⁰C freezer 
• 600µl of solution syringed into a 4mm button well and inserted in a -80⁰C freezer 
After 36 hours in their respective freezers, the samples were removed on dry ice in an ice 
box and inserted into a freeze dryer for 24 hours. Sublimation was confirmed by visual 
assessment. Samples were then soaked overnight in 300ml of dH2O per sample at 37⁰C with 
5% CO2/air to remove unreacted, water soluble cross-linker. Scaffolds were subjected to 10 
minutes of UV irradiation and ozone in a class II biosafety cabinet. Samples were 
subsequently rinsed with PBS before being placed in 100mm petri dishes (larger petri-dishes 
were required due to swollen state of gel) and soaked in cell media 
(DMEM/10%FCS/1%Pen-Strep) for 48 hours at 37⁰C with 5% CO2/air mixture. 
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4.8.2.2 Culture of L929 Mouse fibroblasts on EDCI/NHS crosslinked 5% Gelatin Cryogels – 
“Pizza Slices” 
The two 5% circular samples that underwent cryogelation at -20⁰C were then each sectioned 
into 6 evenly portioned slices and transferred to non-treated, polystyrene 6-well culture 
plates (6-Well, CytoOne® plate, non-treated – StarLab, UK). Each scaffold was assigned to 
its own 6 well plate with one “slice” per well. L929 mouse fibroblasts at passage 16 were 
seeded onto each slice at a density of 0.3 x 106. 2ml of cell media was added to each well 
(DMEM/10% FCS/1% Pen-Step) and cells incubated at 37⁰C with 5% CO2 for a total of 7 
days. Two slices from each plate were fixed at days 1, 3 and 7. Media was carefully changed 
with small pipettes at day 3 for the 7 day samples only. For fixation, samples were 
transferred to a new 6-well plate at the pre-designated time points. Samples were rinsed for 
five minutes in 1x histology PBS before a one hour soak in 4% PFA. After which, samples 
were rinsed twice for five minutes with 1x histology PBS. Samples were then stored in the 
fridge until staining.  
Following fixation of all samples on day 7, the samples were stained and mounted on glass 
slides and visualised using the Carl Zeiss ApoTome Inverted Microscope. Images were 
recorded using the Z-stacking function on the Carl Zeiss Zen software and post processing 
of images was performed using Fiji – an open source platform for biological image analysis 
(Schindelin et al., 2012). Samples were inspected under the microscope and three central 
areas of the gels were imaged. Staining was performed by removing all PBS and rinsing for 
five minutes with 1x histology PBS. Cells were permeabilised with 0.5% Triton™ X-100 for 
15 minutes before being rinsed twice with 1x histology PBS for eight minutes. Alexa Fluor® 
488 phalloidin stain (ThermoFisher Scientific, UK) was mixed with 1x Histology PBS at a 
ratio of 1:250 (60ul:14940ul) and samples were soaked for 30 minutes in 2ml of stain at 4⁰C 
followed by three, five minute rinses with 1x histology PBS. Finally samples were mounted 
on labelled glass slides and covered with ProLong™ Diamond Antifade mountant with 
DAPI (ThermoFisher Scientific, UK) and a glass cover slip before being stored at -4⁰C in a 
dark microscope slide holder before imaging.  
4.8.3 Results  
Due in part to the large dimensions of the cryogels and amount of time and data required to 
image the gels, it was not feasible to image the entire cryogel samples. Furthermore, as cells 
were seeded centrally, cell growth was not evident on all areas of the gels. The 50mm petri-
dish cryogel sample produced by inserting EDCI-NHS crosslinked gelatin into a -80⁰C 
freezer along with the 4mm CBW samples subsequently dissolved when rehydrated 
overnight in dH2O at 37⁰C. Autofluorescence was detected from the remaining gelatin 
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cryogels which was more noticeable using the Cyan filter on the ApoTome i.e. when 
imaging for DAPI Nucleus staining. Figure 26 displays confocal microscope images of L929 
fibroblasts cultured on the 5% gelatin cryogel slices at time points of 24, 72 and 168 hours. 
Whilst increased cell growth and proliferation is visible by day 7, it is not clear why minimal 
cell growth was visible by day 3. Figure 27 shows confocal images of the duplicate 5% 
gelatin cryogel samples with L929 cells fixed the same time intervals of 24, 72 and 168 
hours. A more conventional pattern of cell proliferation and expansion is visible compared 
to Figure 26. Rows 3 and 4 of Figure 27 represent two slices 70µm apart in the Z axis. 
Figure 28 presents an additional region of the day 7 cryogel pictured in Figure 27.  
 
 
Figure 26 L929 Mouse Fibroblasts cultured on 5% gelatin-EDCI-NHS cryogels. Montage confocal microscope 
images taken of the top of the gels representing time points 24 hours, 72 hours and 168 hours from the first 
samples. Left column – DAPI stain. Middle – Actin Stain (Alexa Fluor® 488 phalloidin). Right – DAPI/Actin 
stain. An increase in cell number and cell growth is evident between time points – 24 and 168 hour. 
Furthermore, cell spreading is evident in the bottom right image, which shows the presence of numerous 





Firstly, the crosslinked gelatin scaffolds that underwent cryogelation at -80⁰C dissolved 
upon rehydration with dH2O at 37⁰C. This suggests that these gels were inadequately 
crosslinked, which is interesting because the gels were produced from the same mixture as 
the cryogels that were subsequently seeded with fibroblasts that underwent cryogelation at -
20⁰C. One possible consideration relates to the low concentrations of EDCI and NHS that 
were utilised. The minimum quantity of EDCI required for cross-linking has been defined in 
the literature, which is similar to the molarity used within these experiments (Van 
Vlierberghe, 2016). The lowest concentration was utilised to increase the working time of 
the EDCI-Gelatin mixture to avoid chemical crosslinking prior to casting in the appropriate 
dimensions. It is therefore possible that the rapid freezing process associated with 
cryogelation at -80⁰C reduced the activity of the crosslinking process to such a level that the 
gels were unstable at 37⁰C. Furthermore, it is highly likely that the stable cryogels produced 
at the higher temperatures of -20⁰C had cross-linked prior to freezing and as such these 
cryogels are likely to display different topographical arrangements than cryogels that are 
cross-linked after freezing. In fact, it is possible that the subsequent cryogels, displayed large 
pores that were poorly interconnected, as the ice crystals form within previously gelled 
hydrogel (Plieva et al., 2006), rather than in the unfrozen solution. A poorly interconnected 
gel would impede cell migration. 
The process of ‘ice templating’ during the cryogelation process refers to the process of using 
frozen water crystals to template the subsequent architecture of the cryogel (Bencherif et al., 
2013). The frozen solvent serves to compress the gelatin and crosslinker into smaller areas 
known as the non-frozen liquid microphase in a process also referred to as 
cryoconcentration. The greater concentration of crosslinker and solute serves to accelerate 
the cross-linking reaction. Therefore, rapid freezing, such as that associated with freezing at 
-80⁰C, will also reduce the overall size of the ice crystals formed and will thus increase the 
area of the NFLMP resulting in fewer cross-links. Furthermore, the water-soluble cross-
linkers, may remain confined to the frozen solvent phase and as such may have a reduced 
effect upon the adjacent gel. It has been known for many years that the freezing protocol 
influences the resultant porosity of a scaffold (O'Brien et al., 2004) and further investigation 
regarding the type of freezing protocol and its effect upon the architecture and stability of 





Figure 27 L929 Mouse Fibroblasts culture on 5% gelatin-EDCI-NHS cryogels. Montage confocal microscope 
images representing time points 24 hours, 72 hours and 168 hours from the duplicate samples. Left column – 
DAPI stain. Middle – Actin Stain (Alexa Fluor® 488 phalloidin). Right – Merged DAPI/Actin stain. Note lines 3 
and 4 above (168 hours) represent different slices of the same image 70 microns apart in the Z-axis, 
demonstrating attachment of fibroblasts on the top surface of the gel and also deeper into the cryogel pore 
structure. Pore structure outline has been demarcated with the dashed white line in the top right and bottom 
montage. 
 
Figure 28 L929 mouse fibroblasts cultured on 5% gelatin-EDCI-NHS cryogels. A confocal image of L929 
fibroblasts within the pore structure of a 5% gelatin cryogel at day 7. Left - DAPI. Middle - Actin stain (Alexa 
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Fluor® 488 phalloidin). Right - Merged DAPI/Actin. Note: cells out of focus (Arrow) at the top left of each 
image suggests cell survival at multiple positions (also demonstrated in figure 27) within the gel. The linear 
nature of the cells (outlined by white dashed line in right image) in focus demonstrates cell proliferation within a 
crease or pore of the cyrogel. 
The images shown in section 4.8.3 show L929 fibroblasts cultured on 5% Gelatin-EDCI-
NHS cryogels. Whilst no accurate µCT images were available to accurately calculate the 
pore sizes produced, the confocal images clearly demonstrate a macroporous structure to the 
cryogels, with pore sizes visible in the region of 150-175µm. This suggests that 
macroporous structures can be produced using chemically crosslinked gelatin despite the 
presence of chemical cross-linker prior to freezing. The interconnectivity of these 
macropores within the gels however, remains unknown.  
As the experiment progressed, handling of the gelatin cryogels became more challenging 
due possibly to the imbibition of fluid into the gels and also the breakdown of the ECM by 
cellular enzymes. L929 cell growth on the sample fixed at day 3 in Figure 26 was minimal. 
It is possible that this slice was damaged during processing, because the duplicated image in 
Figure 27 displayed a much greater number of cells with greater spread in line with what 
would be expected following three days in culture. Rows 3 and 4 from Figure 27 represent 
different slices of the same cryogel section. These images clearly show co-localisation of 
cells within the porous structure of the cryogel along with a distribution through the gel of 
approximately 70-80µm. This suggests that macro-porous gels may offer cells an easier 
pathway for migration when compared to conventional hydrogels with a nanoporous 
structure. With regards to the clinical requirements for REPs, rapid speed of migration is 
desirable, allowing cells to penetrate further into the root canals, as well as offering greater 
space for nutrient exchange. Whilst these images are a selective representation of the entire 
cryogels, the large dimensions meant imaging of the entire cryogel was not appropriate for 
these initial pilot investigations into material production and suitability. The images selected 
clearly show fibroblast attachment, proliferation and migration into the macroporous 
cryogels and support previous work within the literature that EDCI-NHS crosslinked gelatin 
is a suitable substrate for tissue engineering purposes (Cammarata et al., 2015, Lai, 2010, 
Liang et al., 2004, Sung et al., 1999, Ulubayram et al., 2002, Van Vlierberghe, 2016, Yang 
et al., 2018). The production strategy utilised appears to be non-cytotoxic and enables cell 
attachment and proliferation.  
The process of ‘freezing after gelation’ has been suggested as a less effective strategy for 
producing macroporous gels, as the interconnectivity between pores is said to be 
compromised (Plieva et al., 2006). Despite this, Figure 28Figure 28 shows cells occupying a 
linear section of the cryogel, which may represent channels present between pores of the 
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gels. Whilst no attempt was made to assess the rate of gelation when EDCI and NHS was 
added to the gelatin, as discussed above, it was clear that the freezing cycle did influence 
subsequent crosslinking. An alternative strategy that should be investigated, involves the 
rehydration of lyophilised gelatin cryogels with EDCI-NHS solution (Van Vlierberghe, 
2016). Using this strategy, no chemical cross-linking would occur prior to freezing, ensuring 
that the cross-linking process would have limited impact upon the resultant cryogel 
structure. In this instance, the freezing cycle utilised could be investigated more predictably.  
Finally, it should be noted that chemically-crosslinked gelatin cryogels fabricated using the 
above strategy, produces a scaffold with defined dimensions and does not represent 
injectable biomaterial technology. As such, these materials offer perceived advantages in 
relation to their macroporosity, but this may reduce their ability to contour to the often 
aberrant and irregular anatomy of the root canal space of an immature tooth.  
4.9 Gelatin cryogels fabricated within the CBWs 
4.9.1 10% Gelatin Cryogels fabricated within the CBWs  
In order to investigate the effects of different freezing cycles upon scaffold porosity, a 10% 
w/v gelatin solution was produced and the solution was pipetted into a range of CBWs and 
either inserted into a freezer for 48 hours at -20⁰C or snap-frozen with liquid nitrogen. 
Samples were subsequently transferred into a freezedryer for 48 hours. After 48 hours, 
samples were removed and visually inspected to ensure the full lyophilisation process had 
occurred. Figure 29 displays the initial 10% gelatin cryogel trials following lyophilisation. 
These samples were cast within the CBWs prior to freezing and lyophilisation. No 
detrimental effects upon the CBW inserts, nor the resin negative were noted from freezing, 
including with liquid nitrogen, suggesting that the insert could withstand cryogenic 
treatment.  
In addition, several plain cryogel samples were re-produced as above and sent for 
assessment with µCT after lyophilising and before rehydrating. Unfortunately, as no contrast 
was added to the solution prior to imaging, the assisting Professor R. Van ‘t Hof was unable 
to extract useful images for comparison between different freezing cycles. Further 






Figure 29 First trials of 10% gelatin cryogels in the CBW: A) Gelatin cryogels in situ within the CBWs 
following lyophilisation B) A single 4mm diameter 10% gelation cryogel removed from the CBW after 
lyophilisation C) 4mm 10% lyophilised gelatin cryogels following careful removal of the CBW insert note: glass 
cover slip used during the inverted fabrication technique is still attached to the cryogels 
4.9.2 5% Gelatin-EDCI-NHS cryogels fabricated within the CBWs 
In order to determine if macroporous gels influenced the degree of migration, a 5% gelatin-
EDCI-NHS solution was produced as previously reported (section 4.2.1). The solution was 
pipetted into a range of 2mm, 3mm and 4mm diameter CBWs using the inverted fabrication 
technique. CBWs were subsequently frozen in a -20⁰C freezer. As discussed in section 4.8, 
trials of different freezing cycles using liquid nitrogen and dry ice were also performed and 
were intended to assess whether the resultant cryogels exhibited different topographical 
arrangement of pores and pore sizes in comparison to the cryogels frozen at -20⁰C. As 
discussed, the absence of contrast from these samples meant the µCT images were not 
interpretable. Furthermore, the ability to snap-freeze the gelatin-EDCI-NHS solution with 
liquid nitrogen may enable the solvent to be frozen prior to physical gelation or chemical 
crosslinking of the gelatin with the EDCI/NHS. It was proposed that this may again 
influence the topography and porosimetry of the resultant cryogels. Figure 30 displays a 




Interestingly, Figure 30e displays a range of individual cryogels post-rehydration in distilled 
water. Whilst some cryogels closely resembled the cylinders in which they were poured, 
some cryogels dissolved, some poorly/partially rehydrated and some retained a cross-linked 
gelatinous component that was grossly different to the cylindrical form pre-rehydration. The 
majority of the cryogels also displayed a white central core, which suggests that water 
penetration into the central aspects of the gels was poor. Once again, this may relate to the 
fact that cross-linker was added to the gelatin solution prior to freezing. However, it was 
hoped that the liquid nitrogen samples, which can be immediately snap-frozen after being 
poured would have reduced the effect of any added EDCI-NHS upon the resultant cryogel 
structure. This did not appear to be the case and the current experiments have raised further 
questions relating to the type of freezing cycle; the concentration of EDCI/NHS; and the 
presence or absence of cross-linker prior to freezing on the structure of the cryogels 
produced.  
As some gels did survive, an attempt was made to reposition gels within the CBWs. These 
CBWs were reverted to their upright position and inserted in a 6 well plate with PBS. 
However, even gels which appeared to fit adequately within the CBW cylinders still tended 
to slip out of the bottom of the CBWs when PBS was added to the upper compartments and 
incubated overnight. As the reliability and validity of any future experiments relies upon the 
ability of the biomaterials to maintain fluid within the upper compartment, movement of the 
scaffolds whilst incubated or in culture is undesirable as any cells seeded on the upper 
compartment could quickly dehydrate or leak into the lower compartment.  
Despite the issues above, these attempted experiments highlighted a number of findings. 
Positive findings were: 
1. The CBW can be used to pour hydrogels and fabricate cryogels in situ.  
2. The Elastosil 601 used to fabricate the inserts can tolerate sub-zero temperatures to 
that of liquid nitrogen (-178⁰c) without detrimental effects.  
3. Prior to rehydrating, the lyophilised 5% gelatin-EDCI-NHS constructs appears 
macroporous with relatively little dimensional change.  
4. Rehydration in distilled water alone did produce some cryogels that were consistent 
with comparable dimensions to their pre-lyophilised state.  
As with all research, a range of additional questions were raised that require further 
investigation:  




2. How does the addition of cross-linker prior to freezing affect the resultant structure 
and porosimetry? 
3. Does the use of different freezing cycles influence the efficacy of the added 
carbodiimide cross-linker? 
4. Is it possible to fabricate cylindrical hydrogels/cryogels that will hold adequately 





Figure 30 First trials of 5% Gelatin-EDCI-NHS Cryogels: 5% Gelatin-EDCI-NHS solution was used in a range 
of CBW diameters utilising the inverted fabrication technique a) Close up of the CBW and cryogels immediately 
post-liquid nitrogen freezing b) Icebox containing dry-ice with CBWs and petri dishes on top for freezing c) 
Multiple CBWs within the freezedryer component prior to lyophilisation d & f) Lyophilised samples re-hydrated 
in 2L of dH2O whilst within the CBWs e) 4 different individual gelatin cryogels removed from the CBWs 




The work above describes the design and fabrication of the CBW, a laboratory insert 
suitable for cell culture. The research presented details the optimisation and validation 
processes that have been attempted, some areas of which will be discussed further in the 
‘future research’ section. Pulp regeneration represents a small branch of tissue engineering, 
which is a vast research field that requires great understanding of cell biology, behaviour and 
interactions. Studying these topics in situ can be extremely challenging and as such, a well-
designed laboratory model could greatly enhance the collective knowledge for the medical 
and dental research communities. The aim of this study was therefore to produce a 
laboratory model specific to pulp regeneration that would enable the further study of the 
above factors, which require specific attention within the field of REPs.  
5.1 The Culture Button Well 
5.1.1 Design overview 
The initial design for the CBW was intended to produce an additively manufactured, in vitro 
insert for cell culture experiments. Adoption of CAD/CAM technology allows for precise 
control over all of the insert dimensions and enabled a product to be additively manufactured 
using commercially available 3D printers using a range of different technologies and 
materials. The initial design parameters used from 6-well culture plate dimensions produced 
an insert that fitted nicely into a 6-well plate with adequate space for media and pipette tips. 
Space was provided for circulation of media in the lower chamber through the addition of 
small feet. The CBW was designed to support vertically orientated tissue scaffolds that 
could bidirectional as this would more accurately replicate the tooth, which could be 
maxillary (i.e. cells above the root canal) or mandibular (i.e. cells below).  
5.1.2 Internal cylindrical design and the ‘critical apical diameter’ 
Internal cylindrical voids were created within the insert for the placement of the biomaterial 
tissue scaffold being investigated. The diameters of these cylinders were selected from a 
radiographic study that recorded the apical diameters of avulsed immature teeth (Kling et al., 
1986). In this study, apices of varying diameters (<1mm to >4.1mm) were reported along 
with the percentage of spontaneous revascularisation. Of the 82 cases that were reported to 
have an apex of less than 1mm, no revascularisation was reported. This study contributed to 
the notion that there was a ‘critical apical diameter’ below which revascularisation may be 
compromised; presumably due to space for angiogenesis. However, regeneration using 
inductive biomaterials presents a different challenge and subsequent studies have shown the 
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diameter may not be as critical as first thought (Laureys et al., 2013, Fang et al., 2018). 
Despite these reported successful outcomes, larger apices tend to be associated with shorter 
roots and as such they may benefit more from regenerative procedures. Anecdotally, larger 
apices also present a greater clinical challenge as they are more difficult to manage using 
conventional root-end barrier apexification. As such, diameters ranging from 2-5mm were 
designed with a maximum number of 20 cylinders and a minimum of 4, diameter dependent.  
5.1.3 Indirect Additive Manufacturing and Casting  
A number of commercially available AM strategies were trialled. Following the printing of a 
successful prototype, the biological requirements of the insert were reassessed. Resin 
polymer based stereolithography and digital light processing systems are predominantly 
methacrylate based and as such any leachates can have detrimental effects upon cells in 
culture. These resins were also coloured or slightly opaque, making the pouring and imaging 
of tissue scaffolds more challenging. A decision to cast the CBW from a translucent 
addition-silicone was made and the resultant inserts were transparent and autoclaveable, 
making them reusable. Cells were able to survive prolonged culture on the inserts and there 
did not appear to be any detrimental effects to the cells. As hydrogels were used for model 
validation, the translucent design also ensured that no bubbles were incorporated into the 
cylinders when injected into the CBW. Bubbles or gaps within the scaffolds would 
frequently have drastic effects upon the positioning of the scaffolds and the ability of the 
CBW to support fluid in the upper compartment.  
The design of a CBW negative did however create some problems due to the large number 
of internal cylindrical voids originally planned (n = 20). As the cylinders had long parallel 
walls, the polyvinylsiloxane and polydimethylsiloxane trialled would frequently tear on 
removal. For the process of optimisation and validation, the number of internal cylinders 
was reduced to four per insert and these could be easily cast and removed from the moulds.  
5.1.4 Validation of the model 
The fourth primary objective was to validate the model using a range of tissue scaffolds. 
Model validation refers to a series of steps that assesses the model’s ability to produce data 
that is reliable, reproducible and robust (Butler, 2014). Validation therefore enables 
researchers to understand the variation that may result from using the model prior to 
conducting experiments to test a specific research question. Fundamentally, without 
appropriate model validation, researchers are unable to conclude that the results they 
recorded occurred as a result of their experiment and not as a result of the model itself. 
Unfortunately, at present the CBW has not been validated for use as an in vitro migration 
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assay tool. Despite this, the research detailed above has highlighted a series of design 
amendments that may enable validation of future CBW iterations.   
5.2 Experimental findings and modifications 
5.2.1 General findings 
The experimentation conducted and presented represents a series of optimisation 
experiments that were ultimately unable to fully validate the CBW model in its current form, 
but there are multiple important findings and results that have resulted in a series of 
recommendations for future research. A large amount of time was invested on scaffold 
fabrication and material trials, which ran concomitantly with cell culture training and basic 
laboratory skills. A number of different materials and fabrication techniques were 
investigated to fully understand the design requirements for the CBW 2.0. In its current 
format, the CBW can be used to fabricate a range of consistent hydrogels and cryogels. 
However, issues arose with prolonged incubation and cell culture.  
The CBW itself is fabricated from the addition-cured rubber, Elastosil 601, which has been 
shown to be a suitable material for an in vitro cell culture insert. This rubber can withstand 
autoclaving, and it can also be subjected to a range of freezing protocols including dry ice 
and liquid nitrogen, which can be used for cryogelation. No dimensional changes were noted 
with prolonged incubation at 37⁰C, but this was not the case for the tested tissue scaffolds, 
which were prone to imbibition and syneresis.  
5.2.2 Controlling the scaffold position 
The most persistent issue that affected this entire research project, was control over the 
position and consistency of the hydrogels and cryogels whilst within the CBW. Initial 
experiments with 10% gelatin and chemically crosslinked gelatin, produced perfectly 
cylindrical hydrogels. Chemical crosslinking with EDCI/NHS was required as the sol-gel 
transition temperature of gelatin is below 37⁰C. When cross-linked, gelatin maintained a 
consistent shape and structure. However, the gels frequently slipped through the bottom of 
the CBW to rest against the floor of the culture plate, this opened gaps around the gel which 
led to the draining of the fluid in the upper compartment. This problem was also evident 
when gelatin cryogels were produced with the CBW. Stiffer cryogel samples may represent 
more ideal handling properties for handling and processing, as they can be removed for 
processing and imaging, but they may also fail to represent the dental pulp in terms of 
mechanical characteristics. Failure to match the physical characteristics of the gels with that 
of dental pulp may influence the resultant cell phenotype and the ultimate tissue that is 
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produced. Further gel/scaffold rheology would be an appropriate strategy for optimising gel 
stiffness.  
When collagen was used, the lack of consistency became more problematic, as the pH-
crosslinked collagen was not rigid enough to support itself within the CBW. As a result, 
these hydrogels would repeatedly drain from the CBW when cover slips were removed, even 
when cross-linking was demonstrated within a bijou flask. Other literature has also reported 
significant dimensional change of collagen gels following cross-linking (Timpson et al., 
2011). After a brief attempt to stiffen the hydrogels with UV-irradiation, the 4mm and 3mm 
CBWs were abandoned in favour of the 2mm cylinders in which the 6mg/ml collagen did 
remain. It is possible that removal of the overlying coverslip was catastrophically disturbing 
the delicate collagen gel cross-linked structure. BSA coating of the cover slips also failed to 
improve the outcome. Any successful collagen hydrogels were often short-lived as 
prolonged incubation in cell media would lead to dimensional changes in the gels, which 
often resulted in part if not all of the gel draining into the lower compartment.  
One method that did help to maintain the collagen gel structure and held the cell media in 
the upper well, was to add a thin layer of surplus collagen to connect the four collagen 
cylinders (Figure 12). Whilst this strategy helped to hold the gels in situ, it also adds to the 
length of the gel and increases the length of the subsequent hydrogel through which the cells 
will be required to migrate.  
In an additional material experiment, 5% EDCI-NHS-gelatin cryogels demonstrated good 
L929 fibroblast cell growth at 7 days with evidence of co-localisation within pore structures. 
It is possible that the macroporosity of these gels is desirable for pulp regeneration as there 
will be less resistance to cell migration and nutrient exchange. Pore size has also been shown 
to influence cell behaviour, with smaller pores associated with cell growth and larger pores 
associated with greater extracellular matrix secretion (Annabi et al., 2010). When fabricated 
within the CBW these gels maintained a good shape and consistency, but as discussed 
earlier, the cryogels tended to slip out of the CBW when media was added to the upper 
compartment.  
When compared to Transwell® inserts, there was no track-etched membrane positioned at 
the lower end of the CBW to support the hydrogels and this contributed to the issues 
highlighted above. To circumvent all of these issues, the CBW 2.0 should be redesigned 
with cone shaped internal voids, as opposed to cylinders. The taper of the cones could be 
tuned to ensure that hydrogels and cryogels are adequately supported during prolonged 
culture, but a fairly modest taper of 5-10% is likely to be sufficient to prevent slippage of the 
gels out of the CBW.  
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5.2.3 Growth factor gradients 
A simple application of bromophenol blue to 1% agarose gels within the CBW has also 
shown that the CBW may be used to produce hydrogels with a molecular gradient (Figure 
25). This may be extremely beneficial for pulp regeneration, whereby the gradient may serve 
to increase the depth and speed of cell migration. If growth factor gradients were included 
and the speed of migration could be enhanced, then it is logical to assume that angiogenesis 
could also be influenced through the controlled placement of pro-angiogenic growth factors. 
Aside from the crude method of soaking the hydrogel in growth factor that was performed 
above, alternative methods such as electrophoresis or fluorescent-labelling of cytokines 
could be more precise strategies for producing and assessing growth factor gradients within 
the CBW hydrogels.  
5.2.4 Imaging considerations 
Cell-seeded hydrogels within the CBW were imaged using a spinning disc confocal laser 
scanning microscope (Figure 16). Whilst the precise measurement into the gel was unclear 
due to technical issues with the microscope, the working depth of the microscope lens was 
considered the limiting factor. As a glass cover slip was placed over the CBW prior to 
imaging, any space between the gel and the cover slip served to reduce the possible depth of 
imaging into the scaffolds. This was particularly problematic when collagen was used, as the 
collagen tended to drain out of the bottom of the CBW during extended culture. As no clear 
migration was demonstrated with collagen hydrogels, an imaging distance of 12mm is 
currently excessive. Shortening the length of the internal cylinders to 5mm would enable the 
entire gel to be imaged with the current lens. This would also serve to shorten the distance 
between the top and bottom of the CBW, so that cells may be more likely to respond to the 
growth factors being used as chemoattractants. It is also possible that cells seeded on top of 
the hydrogel cylinders were too far from the epidermal growth factor and fetal bovine serum 
that was being used as chemoattractant.  
5.2.5 Upper compartment volume 
The upper compartment of the CBW was initially designed to hold 1.5ml of cell media. 
However, with extended culture, this media volume was insufficient as it was imbibed into 
the gels, evaporated off and also drained into the lower compartment. Loss of media into the 
lower compartment was more problematic when the consistency or adaptation of the tissue 
scaffolds were compromised. Furthermore, if excess media were added, the convexity of the 
fluid surface could reach the lid of the tissue culture plate, predisposing to cross-
contamination and infection. It is possible that the current media volume would be adequate 
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when the CBW was redesigned with tapered internal cones as gels are less likely to move 
and media is subsequently less likely to drain. However, as the length of the gels is being 
reduced to assist with imaging, it seems logical to use this reduction in height to increase the 
volume of the upper reservoir.  
5.2.6 CBW Validation 
Whilst model validation was not demonstrated within this work, some of the initial 
processes that may be used are discussed below. As multiple fabrication methods were 
involved, the first part of model validation, would be to ensure that CBWs are accurately 
produced within a respectable standard deviation. SEM or µCT would be reasonable 
techniques to consider for this purpose. As AM strategies develop, it is highly likely that 
indirect AM strategies will no longer be required. Removing the second production stage 
and relying solely on CAD/CAM technology should further enhance the accuracy of the 
CBWs that are produced.  
Once the accuracy of the model has been confirmed, the next stage is to validate the model 
as a suitable tool to study hydrogels. To simplify this process, the use of a pre-validated and 
commercially available hydrogel peptide such as Puramatrix™ would ensure no further 
variation is incorporated as a result of the test material. Finally, once placement and imaging 
of a validated hydrogel had been demonstrated further biocompatibility testing could be 
performed using multiple cell lines to ensure no change in cell behaviour or survival is 
identified as a result of the CBW material.  
5.3 Recommendations for the redesign of the CBW 2.0 
• Decrease the height of the internal tissue scaffold channels from 12mm to 5mm.  
• Increase the height of the upper reservoir from 3mm to 6mm. 
• Design the internal channels with a taper of 5-10% to help support the resultant 
tissue scaffold. 
5.4 Future research using the CBW 2.0 
Acknowledging the design recommendations outlined above and with further optimisation it 
is hoped that the stability of tissue scaffolds within the CBW can be controlled and this will 
help provide further information on a range of different topics in regenerative endodontics. 
Currently there is no specific in vitro model for pulp regeneration reported in the literature. 
Future research topics include: 
• Comparative assessment of biomaterials - It would be realistic to repeat the above 
cell migration experiments using a range of stable hydrogels and cryogels, with 
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comparative assessment of the depth and speed of cell migration using a known 
invasive cell line such as the triple negative, human breast adenocarcinoma line 
(MDA-MB-231) used above.  
• Comparative assessment of different progenitor cells and co-cultures – Successful 
vasculogenesis/angiogenesis relies upon the complex interaction of several cells 
including fibroblasts, endothelial cells and progenitor cells. A range of different cells 
could be trialled with the optimised scaffold to assess cell behaviour including gene 
expression and protein translation. The use of primary cells such as pulp fibroblasts 
and DPSCs would be a logical step in the development of a pulp regeneration 
migration tool.  
• Assessment of cryotreatment protocol on scaffold porosity and interconnectivity – 
By incorporating contrast into the hydrogel solution, µCT could be used to 
comparatively assess the effect of freezing protocol on the pore size and the 
interconnectivity of gels.  
• The effect of different chemoattractant profiles on cell migration – It has been 
reported that dentine conditioning with different irrigants, medicaments and cements 
during -clinical treatment releases different dentine-sequestered growth factors. 
Once a stable biomaterial has been chosen, it is hoped the effect of different 
combinations of these sequestered growth factors could be studied.  
• Assessment of alternative biological processes such as mineralisation.  
6 Conclusions 
The present study details the design and fabrication of an in vitro model that is specific for 
pulp regeneration called the ‘Culture Button Well’. As an additively manufactured insert, the 
geometry of the internal voids can be modified to replicate a range of possible root canal 
configurations that may present for regenerative endodontic procedures. The CBW can be 
used to fabricate hydrogels and cryogels in situ, and cell imaging can be performed without 
removal of the tissue scaffolds from the CBW. The CBW may be suitable for the assessment 
of growth factor gradients on cell migration as well as enabling the study of more complex 
ECM-cell interactions by modifying scaffold chemical and mechanical characteristics. 







Appendix A – Supplemental video of a 300µm Z-Stack of a 4mm diameter, 6mg/ml collagen 
















Appendix B – Supplemental video of a Cell exclusion zone assay with GFP-L929 fibroblasts 




Appendix C - Supplemental video of a Cell exclusion zone assay with MDA-MB-231 
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